See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Join us! · SLAS2012 1st Annual Conference & Exhibition · San Diego, California · February 4-8, 2012 · Booth 445

Research Area · Inflammation

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10976 10-HDA New 14113-05-4 ≥98% 2011-10-13 3.052461955995 10-hda fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen 3.052461955995
10008128 10(S),17(S)-DiHDoHE Exclusive 871826-47-0 ≥98% ✓ 2007-08-21 141.926705801105 10-s-17-s-dihdohe PDX; Protectin DX inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 10(s), 17(s)-dihdohe protectin-dx protectindx 141.926705801105
20140 12-oxo Leukotriene B4 136696-10-1 ≥95% 2009-03-06 30.187524861878 12-oxo-leukotriene-b4 12-keto LTB4; 12-oxo LTB4 LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 30.187524861878
34560 12(R)-HETE 82337-46-0 ≥98% 33.588867403314 12-r-hete hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases 33.588867403314
10007247 12(R)-HETE Lipid Maps MS Standard 82337-46-0 ≥98% 2009-02-17 20.338798342541 12-r-hete-lipid-maps-ms-standard hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards 20.338798342541
10010425 13,14-dihydro-15-keto Prostaglandin D1 Exclusive - >98% ✓ 2008-05-09 0.494944751381 13-14-dihydro-15-keto-prostaglandin-d1 13,14-dihydro-15-keto PGD1 PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways 0.494944751381
13100 13,14-dihydro-15-keto-tetranor Prostaglandin D2 Exclusive - ≥95% ✓ 2009-10-28 70.601668508287 13-14-dihydro-15-keto-tetranor-prostaglandin-d2 PGDM metabolites PGD2 CRTH2 DP2 tetranors agonists prostaglandins receptors CRTH2/DP2 70.601668508287
13101 13,14-dihydro-15-keto-tetranor Prostaglandin E2 Exclusive 20675-85-8 ≥95% ✓ 2009-10-23 21.485441988950 13-14-dihydro-15-keto-tetranor-prostaglandin-e2 PGEM metabolites 13,14-dihydro-15-keto PGE2 CRTH2 PGs tetranorPGEM tetranor-PGEM 21.485441988950
20150 14,15-dehydro Leukotriene B4 114616-11-4 >97% 2008-06-02 40.280198895027 14-15-dehydro-leukotriene-b4 14,15-dehydro LTB4 leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition 40.280198895027
10009286 (±)14(15)-EET-SI 218461-97-3 ≥95% 2007-05-14 14.249668508287 -14-15-eet-si (±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF 14.249668508287
10011360 14,15-Leukotriene C4 75290-60-7 >95% 2008-05-23 28.495801104972 14-15-leukotriene-c4 EXC4; Eoxin C4; 14,15-LTC4 leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory 28.495801104972
10011362 14,15-Leukotriene E4 1000852-57-2 ≥97% 2008-11-15 53.443504340962 14-15-leukotriene-e4 14,15-LTE4; EXE4; Eoxin E4 leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes 53.443504340962
10011677 15-Lipoxygenase-1 Western Ready Control Exclusive - Whole cell lysate ✓ 2008-06-17 19.612549936251 15-lipoxygenase-1-western-ready-control 15-LOX-1 Western Ready Control; 15-LO-1 Western Ready Control proteins 15LO1 lipoxygenases 15(S)-HETE 13(S)-HODE 15S-HETE 13S-HODE interleukins western blots WBs immunoblotting blotting 19.612549936251
10011263 15-Lipoxygenase-2 (human recombinant) - >95% 2008-03-25 47.106482504604 15-lipoxygenase-2-human-recombinant 15-LO-2; 15-LOX-2 arachidonic acids recombinant proteins 15-HETE 15-HpETE 47.106482504604
10010468 15-Lipoxygenase Inhibitor 1 Exclusive 928853-86-5 ≥98% ✓ 2008-10-23 39.612962761560 15-lipoxygenase-inhibitor-1 15-LO Inhibitor 1 15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants 39.612962761560
10174 16(17)-EpDPE - ≥90% 2004-01-14 24.642145488029 16-17-epdpe 16,17-epoxy Docosapentaenoic Acid; 16,17 EDP epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP 24.642145488029
13532 17-phenyl trinor Prostaglandin E2 ethyl amide Exclusive - ≥98% ✓ 2010-05-04 393.942559852670 17-phenyl-trinor-prostaglandin-e2-ethyl-amide 17-phenyl trinor PGE2 ethyl amide 17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs 393.942559852670
10005099 17(R)-HDoHE Exclusive 155976-53-7 ≥98% ✓ 2005-01-05 23.108334648776 17-r-hdohe 17(R)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 23.108334648776
13060 17(R)-Resolvin D1 Exclusive 528583-91-7 ≥95% ✓ 2008-12-18 147.893958129041 17-r-resolvin-d1 AT-RvD1; Aspirin-triggered-Resolvin D1; 17(R)-RvD1 EPAs DHAs resolvins inflammation antiinflammatory anti-inflammatory immune response aspirin LOXs 17R ATRvD1 17RRvD1 147.893958129041
10009799 17(S)-HDoHE - ≥98% 2007-03-12 10.314438305709 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 10.314438305709
13185 17(S)-HpDoHE - ≥98% 2009-07-02 5.554861878452 17-s-hpdohe 17(S)-hydroperoxy Docosahexaenoic Acid inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα 17(s)-hpdohe 17s-hdohe 5.554861878452
20170 18-carboxy dinor Leukotriene B4 102674-12-4 ≥97% 2009-02-24 212.123613259668 18-carboxy-dinor-leukotriene-b4 18-carboxy dinor LTB4 LTs leukotrienes metabolism β-oxidation β oxidation liver LTBs 212.123613259668
10175 19(20)-EpDPE - ≥98% 2004-01-14 34.476961325966 19-20-epdpe 19,20-epoxy Docosapentaenoic Acid; 19,20 EDP metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP 34.476961325966
10009431 1-Stearoyl-2-Arachidonoyl PC-d8 Exclusive - 99% deuterated product ✓ 2009-07-24 15.738204419889 1-stearoyl-2-arachidonoyl-pc-d8 SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8 SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards 15.738204419889
10006330 2,3-dinor Thromboxane B1 - >98% 2005-03-02 87.129376479873 2-3-dinor-thromboxane-b1 2,3-dinor TXB1 metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits 87.129376479873
9000683 25-hydroxy Vitamin D3 New 19356-17-3 ≥98% 2012-01-12 75.555555555556 25-hydroxy-vitamin-d3 Rovimix Hy-D; RO 8-8892; U 32070E; 25-hydroxy Cholecalciferol 25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum 75.555555555556
13222 2-Acetyl-5-tetrahydroxybutyl Imidazole 94944-70-4 ≥95% 2009-10-08 59.136795580110 2-acetyl-5-tetrahydroxybutyl-imidazole THI; 2-ATHBI; 2-Acetyl-4-tetrahydroxybutyl Imidazole sphingosines-1-phosphates S1P lyases S1PL inhibitors lymphatic tissues lymphocytes egress thymus lymphoid organs lymphopenia immunosuppression 59.136795580110
10007980 3,4-DAA - ≥95% 2006-08-09 4.204751381216 3-4-daa Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines 4.204751381216
10397 3-amino Benzamide New 3544-24-9 ≥98% 2011-10-07 4.889884728190 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 4.889884728190
9000785 3-Deazaadenosine 6736-58-9 ≥98% 2011-06-14 0.693370165745 3-deazaadenosine c3Ado; deaza-Ado; DZA S-adenosylhomocysteine hydrolases homocysteine S-adenosylmethionine methyltransferases inhibitors SAH anti-inflammatory NF-κB NF κB NF kB anti-viral anti-bacterial inflammation infectious diseases leukocytes chemotaxis lymphocyte-mediated cytolysis phagocytosis degranulation signaling 3-DZA ado inhibits inhibition SAM 0.693370165745
10008445 3-methoxy Limaprost - >98% 2006-05-25 33.351022099447 3-methoxy-limaprost 3-methoxy-2,3-dihydro-Limaprost; 3-methoxy-17α,20-dimethyl-Δ2-Prostaglandin E1 PGE1 prostaglandins platelets aggregation inhibits inhibitors inhibition analog ADP collagen-induced adhesiveness 33.351022099447
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 120.923977900552 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 120.923977900552
10007820 5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody - 2006-09-13 8.060798593671 5-lipoxygenase-phospho-ser523-polyclonal-antibody 5-LO (Phospho-Ser523) Polyclonal Antibody wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting 8.060798593671
10006618 5-OxoETE Receptor Blocking Peptide - 2005-03-07 0E-12 5-oxoete-receptor-blocking-peptide TG1019; R527 antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty 0E-12
100025 5-OxoETE Receptor Polyclonal Antibody - 2004-12-14 200.210073664825 5-oxoete-receptor-polyclonal-antibody TG1019; R527 WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting 200.210073664825
90420 5(S),14(R)-Lipoxin B4 98049-69-5 >95% 2008-11-17 45.603732351136 5-s-14-r-lipoxin-b4 5(S),14(R)-LXB4 LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors 45.603732351136
90415 5(S),6(R),15(R)-Lipoxin A4 171030-11-8 ≥95% 2008-11-17 100.229958563536 5-s-6-r-15-r-lipoxin-a4 5(S),6(R),15(R)-LXA4; AT-Lipoxin A4; 15-epi Lipoxin A4 inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered 100.229958563536
10005032 5(S),6(R)-7-trihydroxymethyl Heptanoate - ≥95% 2007-06-13 103.434033149171 5-s-6-r-7-trihydroxymethyl-heptanoate BML-111 lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear 103.434033149171
10009999 5(Z),11(Z),14(Z)-Eicosatrienoic Acid 7019-85-4 ≥98% 2007-08-08 2.225303867403 5-z-11-z-14-z-eicosatrienoic-acid Sciadonic Acid; 5,11,14,20:3 inflammation PUFA fatty acids MPSO maritime pine seed oil Pinus pinaster inflammatory (5z,8z,11z)-eicosa-5,8,11-trienoic acid 2.225303867403
10010484 5(Z),14(Z)-Eicosadienoic Acid Exclusive 122055-58-7 ≥98% ✓ 2008-11-21 18.420607734806 5-z-14-z-eicosadienoic-acid fatty acids polyunsaturated PUFAs 18.420607734806
10878 7(R)-Maresin 1 New 1268720-28-0 ≥95% 2012-02-01 208.234595457336 7-r-maresin-1 7(R)-MaR1 docosahexaenoic acids DHA macrophages zymosan inflammation phagocytosis fatty brain retina murine peritonitis FITC 7(R) maresin 1 mar 1 208.234595457336
10546 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid Exclusive 887752-13-8 ≥98% ✓ 2010-10-22 4.819226519337 7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid 7(S),17(S)-hydroxy DPA opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids 4.819226519337
13161 7(S)-Maresin 1 Exclusive 1268720-66-6 ≥95% ✓ 2010-08-19 87.872871812043 7-s-maresin-1 7(S)-MaR1 docosahexaenoic acids DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 inflammation antiinflammatory anti-inflammation antiinflammation Docosahexaenoic Acid 87.872871812043
13655 Adapalene 106685-40-9 ≥98% 2010-09-10 4.513752572853 adapalene Differin; CD 271 agonists retinoic acids differentiation anti-inflammatory inflammation antiinflammatory anti inflammatory RARs RAR-β RARβ β RAR-b RARb RARbeta RAR-beta RAR-.beta. RAR.beta. RAR-γ RARγ RARg RAR-g RARgamma RAR-gamma RAR.gamma. RAR-.gamma. CD-271 CD271 Naphthalenes 4.513752572853
13297 AG-126 118409-62-4 ≥95% 2009-07-14 6.235295974743 ag-126 Tyrphostin AG-126 tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation 6.235295974743
19023 AH 23848 (calcium salt, hydrate) - ≥90% 2009-02-26 57.782110497237 ah-23848-calcium-salt-hydrate AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 57.782110497237
10010241 AICAR 2627-69-2 >98% 2008-02-25 144.720110497237 aicar NSC 105823; Acadesine; AICA Riboside AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide 144.720110497237
10010332 AMP-Deoxynojirimycin Exclusive 216758-20-2 ≥95% ✓ 2008-11-21 32.067061504904 amp-deoxynojirimycin Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells 32.067061504904
13144 Anacardic Acid 16611-84-0 ≥98% 2010-02-12 3.666163548292 anacardic-acid 6-pentadecyl Salicylic Acid HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 3.666163548292
11001 Anatabine New 2743-90-0 ≥95% 2011-11-10 5.892764857881 anatabine alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells 5.892764857881
500830 Anti-Ovalbumin IgG1 (mouse) EIA Kit New - 2011-11-21 45.892879066912 anti-ovalbumin-igg1-mouse-eia-kit EIAs enzymes immunoassays immunometric kits assays measures measurements eggs whites immunization mice mouse chickens albumin OVA precipitate complexes aluminum hydroxides alum TH2-mediated immune response immunity OVA/alum immunized anti-OVA antibodies IgG1 IgE isotypes mediate tissue-specific tissues effectors chronic inflammation allergic asthma rhinitis cutaneous hypersensitivity antibody plasma serum immunoglobulin OVA-specific TH2 45.892879066912
10010275 Apigenin 520-36-5 >98% 2008-02-18 129.604295580110 apigenin Versulin; NSC 83244; Flavone; Chamomile flavonoids flavones CK2 inhibitors inhibits inhibition inflammatory response anti-inflammatory anti-oxidant NO PGE2 iNOS COX-2 I.kappa.B.alpha. NF-.kappa.-B renal cortex 129.604295580110
10008463 ApoAI Polyclonal Antibody - 2006-03-30 25.340576164167 apoai-polyclonal-antibody Apolipoprotein A-I; Apolipoprotein AI atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting 25.340576164167
90010 Arachidonic Acid 506-32-1 ≥98% 64.728443288917 arachidonic-acid fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential 64.728443288917
10007466 Arachidonic Acid-biotin - >98% 2005-11-30 31.946850828728 arachidonic-acid-biotin fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated 31.946850828728
10008617 Arachidonic Acid Leelamide - ≥95% 2006-09-27 13.535856353591 arachidonic-acid-leelamide AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic 13.535856353591
10007268 Arachidonic Acid Lipid Maps MS Standard 506-32-1 ≥98% 2009-07-06 16.614843462246 arachidonic-acid-lipid-maps-ms-standard fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards 16.614843462246
13622 AS-041164 Exclusive 1146702-72-8 ≥98% ✓ 2010-01-25 11.629944751381 as-041164 phosphoinositides 3-kinases PI3K cells growth migration metabolism inhibitors inhibits PI3Kα PI3Kβ PI3Kγ PI3Kδ chemotaxis inflammation neutrophils AS041164 AS-041164 RANTES 11.629944751381
10009052 AS-252424 900515-16-4 >95% 2007-01-30 30.681124704024 as-252424 phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 30.681124704024
10010175 AS-604850 Exclusive 648449-76-7 >98% ✓ 2007-07-23 15.631664364640 as-604850 phosphoinositides 3-kinases PI3-kinase PI3-K phosphatidylinositol inflammatory drugs inflammation arthritis rheumatoid peritonitis neutrophils recruitment PtdIns inhibitors inhibits inhibiton PI3K 15.631664364640
10007707 AS-605240 648450-29-7 >98% 2007-06-13 28.390828729281 as-605240 phosphoinositide 3-kinases PI3-kinase PI3-K PI3K phosphoinositide phosphatidylinositols inibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 28.390828729281
9000980 AS-605240 (potassium salt) Exclusive - ≥98% ✓ 2011-03-25 21.879921073402 as-605240-potassium-salt phosphoinositides 3-kinases PI3-kinases PI3-K PI3K phosphatidylinositols inhibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240 as 605240 PIs salts solubility soluble 21.879921073402
13160 AT-56 Exclusive 162640-98-4 ≥95% ✓ 2010-06-22 14.504524248004 at-56 Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP 14.504524248004
10277 ATB-337 912758-00-0 ≥98% 2008-11-11 14.931695314099 atb-337 ACS 15; S-Diclofenac inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfides gasotransmitter vasodilator atb337 ACS-15 ACS15 ACS S SDiclofenac Diclofenac 14.931695314099
13045 ATB-343 Exclusive 1000700-26-4 ≥98% ✓ 2008-11-09 14.841455903417 atb-343 inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfide gasotransmitter vasodilator atb343 14.841455903417
600140 Autophagy/Cytotoxicity Dual Staining Kit - 2009-07-14 78.680428176795 autophagy-cytotoxicity-dual-staining-kit assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis 78.680428176795
10803 Autotaxin (human recombinant) - ≥95% 2011-04-04 24.023403314917 autotaxin-human-recombinant Ectonucleotide Pyrophosphatase/Phosphodiesterase-2; Lysophospholipase D; ENPP-2 lipids hydrolysis lysophophatidyl choline lysophophatidic acids secreated glycosylated 24.023403314917
700580 Autotaxin Inhibitor Screening Assay Kit - 2011-06-28 25.737613259668 autotaxin-inhibitor-screening-assay-kit ATX Inhibitor Screening Assay Kit kits assays measures measurements Ectonucleotides Pyrophosphatase-2 ENPP-2 Lysopholipases D hydrolysis lysophosphatidylcholines LPC lysophosphatidic acid LPA lipids mediators G protein-coupled receptors GPCRs neurogenesis angiogenesis smooth-muscles contraction platelets aggregations wounds healings ATX-LPA signaling tumors progression inflammation serums proteolytically peptides proteins N-glycosylation Asn53 Asn410 adipocytes cerebrospinal fluid multiple sclerosis livers fibrosis cancers genes chips analysis upregulated metastatic inhibits inhibition human 25.737613259668
10011336 Avenanthramide-C methyl ester Exclusive 955382-52-2 ≥95% ✓ 2009-06-18 67.141074836765 avenanthramide-c-methyl-ester Inhibitors NF-κB IL-6 IL-8 MCP-1 IκB inhibits inhibition Interleukins 67.141074836765
13823 AX 048 Exclusive 873079-69-7 ≥98% ✓ 2010-09-15 9.311602209945 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 9.311602209945
10010266 BAY-11-7082 19542-67-7 ≥98% 2008-07-25 28.859627455494 bay-11-7082 inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 28.859627455494
10960 Bisdemethoxycurcumin New 24939-16-0 ≥98% 2011-08-09 5.118768935040 bisdemethoxycurcumin BDMC curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 5.118768935040
11071 BRD2 bromodomain 1 (human recombinant) New - ≥95% 2011-10-21 32.055513448191 brd2-bromodomain-1-human-recombinant RNF3; Bromodomain containing 4; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 32.055513448191
11070 BRD2 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 32.055513448191 brd2-bromodomain-2-human-recombinant RNF3; RING3; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomain epigenetics lysine inflammatory inflammation mitosis viral host 32.055513448191
11069 BRD2 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 63.578400101523 brd2-bromodomains-1-and-2-human-recombinant Bromodomain containing 2; RNF3; RING3 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 63.578400101523
11068 BRD4 bromodomain 1 (human recombinant) New - ≥60% 2011-10-21 43.373060618001 brd4-bromodomain-1-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 43.373060618001
11066 BRD4 bromodomain 2 (human recombinant) New - ≥95% 2011-10-21 34.531928542530 brd4-bromodomain-2-human-recombinant MCAP; Bromodomain containing 4; HUNK1 BET proteins BRD2 BRD3 BRD4 I-BET genes expression histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysine nucleosomes cellular inflammatory mitosis viral hosts 34.531928542530
11052 BRD4 bromodomains 1 and 2 (human recombinant) New - ≥90% 2011-12-20 66.606350412082 brd4-bromodomains-1-and-2-human-recombinant HUNK1; MCAP; Bromodomain containing 4 BET proteins BRD2 BRD3 BRD4 I-BET genes expressions histones chromatin acetylation IBET BRD BRD-2 BRD-3 BRD-4 bromodomains epigenetics lysines regulations trandcription proteins domains nucleosomes BRDT BRD-T cells inflammatory inflammation mitosis viruses viral hosts binding binds molecules inhibitors inhibits inhibition humans diseases 66.606350412082
10009599 Calcipotriol (hydrate) 112828-00-9 >98% 2008-02-08 41.085607734806 calcipotriol-hydrate Calcipotriene (hydrate) vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response 41.085607734806
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 12.442320441989 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 12.442320441989
13907 Caspase-1 Monoclonal Antibody (Clone 14F468) - 2010-07-12 4.178792423046 caspase-1-monoclonal-antibody-clone-14f468 IL-1β Converting Enzyme antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins IL-1β ICE IL1β IL-1b IL1b apoptosis inflammatio 4.178792423046
70635 CAY10416 443919-96-8 >95% 2007-07-24 32.200069060773 cay10416 COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines 32.200069060773
10007955 CAY10498 863202-33-9 >98% 2006-08-02 31.125340699815 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 31.125340699815
10008657 CAY10502 Exclusive - >98% ✓ 2007-08-02 2.664198895028 cay10502 cPLA2.alpha. phospholipases inflammation inhibitors inhibits inhibition arthritis inhibitory cPLA2 AA arachidonic inflammatory inflammation 3-methyl hydrogen 1-[3-(4-decyloxy phenoxy)-2-oxopropyl] indole-3,5 dicarboxylate 2.664198895028
10009536 CAY10512 Exclusive 139141-12-1 >97% ✓ 2007-07-18 34.858370165745 cay10512 analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis 34.858370165745
10010088 CAY10526 Exclusive 938069-71-7 >98% ✓ 2007-09-07 354.735524861878 cay10526 mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions 354.735524861878
10010032 CAY10570 Exclusive 875014-22-5 >98% ✓ 2008-06-03 15.524157458564 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 15.524157458564
10011248 CAY10575 916985-21-2 ≥95% 2008-09-03 26.612367797948 cay10575 IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB 26.612367797948
10011249 CAY10576 862812-98-4 ≥95% 2008-09-08 34.493710865561 cay10576 IKK-.epsilon. IKK.epsilon. IKK-epsilon IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition 34.493710865561
10012424 CAY10583 Exclusive 862891-27-8 ≥98% ✓ 2009-07-21 63.720202578268 cay10583 LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation 63.720202578268
13164 CAY10589 Exclusive 1077626-52-8 ≥98% ✓ 2009-06-23 1.599972375690 cay10589 Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling 1.599972375690
13181 CAY10590 Exclusive 1101136-50-8 ≥98% ✓ 2009-04-15 16.014672454617 cay10590 sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells 16.014672454617
10012553 CAY10595 Exclusive 916047-16-0 ≥97% ✓ 2009-07-08 9.548885819521 cay10595 DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs 9.548885819521
10012539 CAY10597 916046-55-4 ≥98% 2009-03-11 4.402861878453 cay10597 DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid 4.402861878453
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 68.911458563535 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 68.911458563535
10009796 CAY10602 374922-43-7 ≥95% 2009-07-15 19.458428483732 cay10602 SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB 19.458428483732
13381 CAY10606 1159576-98-3 ≥98% 2009-12-04 95.232628992345 cay10606 5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition 95.232628992345
13615 CAY10614 Exclusive 1202208-36-3 ≥98% ✓ 2010-03-22 9.724060773481 cay10614 1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation 9.724060773481
13695 CAY10638 Exclusive - ≥98% ✓ 2010-10-01 28.346174033148 cay10638 Thiazolidinedione derivative prostaglandins 15-PGDHs thiazolidinediones inhibitors inhibits inhibition TZDs derivatives PGDHs dehydrogenases 28.346174033148
10804 CAY10649 Exclusive - ≥98% ✓ 2011-04-04 18.829767549774 cay10649 5-LO leukotrienes 5-lipoxygenases inhibitors inflammation smooth muscle contraction inhibition inhibited PMNL inflammatory 18.829767549774
10743 CAY10650 Exclusive 1233706-88-1 ≥98% ✓ 2011-06-14 23.657458563536 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 23.657458563536
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 28.189119272017 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 28.189119272017
10010117 CB-52 Exclusive 869376-90-9 ≥98% ✓ 2007-10-25 15.747679558011 cb-52 cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic 15.747679558011
10009852 CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8) - 2008-09-03 0.485303867403 cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8 antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 IF immunofluorescence 0.485303867403
10232 CD5 Monoclonal FITC Antibody (Clone CRIS1) - 2009-08-10 4.593489871086 cd5-monoclonal-fitc-antibody-clone-cris1 Tp67; Leu1; T1 antibodies CDs flow cytometry immunocytochemistry ICC FC B-cells T-cell B T IHC IF immunofluorescence immunohistochemistry 4.593489871086
13519 Celastramycin A Exclusive 491600-94-3 ≥97% ✓ 2010-01-25 2.254419889502 celastramycin-a inhibits inhibitors bacterias mycobacterias inflammation IL-8 IL 8 IL8 HUVECs endothelial cells TNF-α TNFα TNF α inhibition interleukins tumors necrosis factors TNF alpha TNF.alpha. inflammatory bioactive endophytic celastraceae pyrroles 2.254419889502
13322 CGP 57380 522629-08-9 ≥95% 2009-08-28 31.493305709024 cgp-57380 MNK1 Inhibitor inhibitors inhibits inhibitions MAPKs MAP kinases interacting interacting-kinase 1 MNK1 p38 JNK1 ERK1/2 PKC Src-like phosphorylation elF4E TNF-a TNF-α TNFα TNFa arsenite anisomycin PMA fetal calf serum 293 cells RAW264.7 toll-like receptors TLR2 HKLM TLR4 LPS TLR6/2 FSL TLR7 imiquimod TLR9 CpG DNA CGP57380 CGP-57380 31.493305709024
10325 Chemokine-Like Receptor 1 Polyclonal Antibody - 2010-01-25 67.220178023327 chemokine-like-receptor-1-polyclonal-antibody Resolvin E1 Receptor; GPCR ChemR23; ChemerinR; DEZ; CMKLR1; ChemR23 immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR 67.220178023327
16831 Cicaprost Exclusive 94079-80-8 ≥98% ✓ 2010-09-16 50.963490708187 cicaprost ZK 96480 Prostaglandin I2 PGI2 prostacyclins vasodilators cardiovascular diseases inflammation mitogenesis cancers orally active inflammatory Epoprostenol Sodium(5Z,9alpha,11alpha,13E,15S)-Isomer Epoprostenol Sodium Prostaglandin I(2) Prostaglandin I2 Prostacyclin Epoprostenol Epoprostanol Flolan PGI2 PGX 50.963490708187
10858 Cinnamyl-3,4-dihydroxy-α-Cyanocinnamate 132465-11-3 ≥97% 2011-06-28 20.425552486187 cinnamyl-3-4-dihydroxy-cyanocinnamate CDC inhibitors 5-LO 5LO 12LO 15LO 5 LO 12 LO 15 LO 12-LO 15-LO LTB4 lipoxygenases immune responses inflammation inhibits inhibition A23187 platelets shock assays 20.425552486187
10004235 cis-Resveratrol 61434-67-1 >98% (may contain 1-5% trans) 2008-02-05 26.492569060773 cis-resveratrol (Z)-Resveratrol antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 26.492569060773
9000760 Colchicine 64-86-8 ≥98% 2011-05-25 3.357182320442 colchicine microtubules polymerization mitosis anti-proliferation anti-inflammatory gout uric acids antiinflammatory antiproliferation 3.357182320442
10009624 COX-2 (human) Western Ready Control - Whole cell lysate 2007-04-30 52.188902920284 cox-2-human-western-ready-control Cyclooxygenase-2; Prostaglandin H Synthase 2 western blots WB PGHS-2 Prostaglandin H Synthase 2 cyclooxygenase 2 52.188902920284
10010096 COX-2 (mouse) Polyclonal FITC Antibody Exclusive - ✓ 2008-04-23 30.223609576427 cox-2-mouse-polyclonal-fitc-antibody Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2 antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting IF immunofluorescence 30.223609576427
700200 COX Fluorescent Activity Assay Kit - 2008-07-24 80.561709457263 cox-fluorescent-activity-assay-kit Cyclooxygenase Fluorescent Activity Assay Kit cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 80.561709457263
13183 CP 80633 135637-46-6 ≥98% 2010-05-20 11.031657458563 cp-80633 phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 Pyrimidinones Pyrimidones 11.031657458563
10011236 C-Reactive Protein (human) EIA Kit - 2009-04-22 295.742828729282 c-reactive-protein-human-eia-kit CRP (human) EIA Kit atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs 295.742828729282
580200 CTRP3 (human) EIA Kit New - 2012-01-20 9.183477357510 ctrp3-human-eia-kit Complement C1q TNF-related Protein 3 kits assays EIAs ELISAs enzymes immunoassays measures measurements complements C1q TNF-related tumors necrosis factor-relateds proteins 3 secreted glycoproteins morphogenesis metabolisms cells functions cellular paralog adiponectins adipocytes leukocytes blood chondrogenic differentiations bone cartilage angiogenesis ERF1/2 signaling signalling adipokines mice mouse humans recombinants suppresses suppression hepatic livers glucose sugar C6H12O6 output inhibition inhibits inhibitors gluconeogenesis levels normal ob/ob obese/obese antagonizes lipopolysaccharides LPS toll-like receptors 4 TLR4 competitive serums plasmas cultures supernatants 9.183477357510
10329 Cystathionine γ-Lyase (human recombinant) - ≥85% 2010-02-19 5.410607734807 cystathionine-lyase-human-recombinant CTH; Cystathionase; CGL cystathionases CTH CGL cystathionines gamma-lyase γ homocysteine transsulfuration cysteines hydrogen sulfides cystathionine gamma-lyase proteins enzymes .gamma.-lyase g-lyase 5.410607734807
10009291 Cysteinyl Leukotriene Express EIA Kit - 2008-08-11 219.284615770969 cysteinyl-leukotriene-express-eia-kit CysLT Express ELISA Kit solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs 219.284615770969
10961 Demethoxycurcumin New 22608-11-3 ≥98% 2011-09-23 4.329129423102 demethoxycurcumin DMC curcumin cancers transcription genes expressions p300 Wnt/β-catenin iNOS inflammation proliferation cells p300 coactivator inhibits lipopolysaccharides inhibitor inhibition 4.329129423102
11015 Dexamethasone New 50-02-2 ≥98% 2011-10-25 64.769483804571 dexamethasone MK 125; NSC 34521 steroids hormones glucocorticoid agonist receptors inflammation genes expression anti-inflammatory antiinflammatory anti inflammatory 8054-59-9 137098-19-2 906362-70-7 906422-84-2 1050677-47-8 adexone aeroseb-Dex aphtasolon aphthasolone azium calonat corsone cortisumman decacort decaderm decadron A decalix decasone dekacort dekort delipos deltafluorene dergramin deronil desadrene desameton deseronil dexa-cortidelt dexa-mamallet dexa-scheroson dexa-sine dexacort dexacortal dexacortin dexadeltone dexafarma dexalona dexaltin dexameth dexamethasone alcohol dexamonozon dexapolcort dexapos dexaprol dexason dexasone dexinoral dexmethsone dexone dexonium dextelan dinomon diodex etacortilen fluormone fluorocort gammacorten gentalipos HL-dex hexadecadrol hexadrol isopto-dex lokalison F loverine luxazone MK-125 MK125 maxidex millicorten NSC-34521 NSC34521 oradexon pet-derm III posurdex prednisolon F prednisolone superprednol surodex visumetazone 64.769483804571
10010948 DL-Propargyl Glycine (hydrochloride) - ≥98% 2008-08-19 46.902047268263 dl-propargyl-glycine-hydrochloride PAG (hydrochloride) H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine 46.902047268263
9090310 Docosahexaenoic Acid ethyl ester 1020718-25-5 ≥98% 2009-01-15 60.476077348066 docosahexaenoic-acid-ethyl-ester DHA ethyl ester; Cervonic Acid ethyl ester fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism 60.476077348066
10460 Doramapimod 285983-48-4 ≥98% 2011-06-02 17.570828729282 doramapimod BIRB-796 p38 MAPKs inflammation TNFα TNF-α TNF α TNFalpha TNF-alpha TNF alpha JNKs inhibitors proteins kinases tumors necrosis factors LPS THP.1 cells THP1 BIRB796 BIRB 796 mitogen activated mitogen-activated proinflammatory cytokins interleukin-1 IL IL-1 interleukin 1 17.570828729282
101640 DP1 Receptor Polyclonal Antibody - 2004-10-22 20.098715469613 dp1-receptor-polyclonal-antibody Prostaglandin D2 Receptor 1; PGD2 Receptor 1 isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting 20.098715469613
500480 dsDNA Autoantibody (human) EIA Kit New - 2011-10-07 0E-12 dsdna-autoantibody-human-eia-kit Anti-double stranded DNA EIA EIAs ELISAs enzymes immunoassays kits measures measurement autoimmunity neutrophils extracellular traps NETs histones peptides deoxyribonucleic acids DNAse I-mediated DNA-degrading plasma systemic lupus erythematosus SLE autoantibodies double stranded dsDNA IgG anti-dsDNA autoimmune diseases immunometric isotypes human serum affinity-purified antibody calf thymus poly-L-lysine protamine sulfate 0E-12
10007963 E-64 66701-25-5 ≥98% 2009-11-12 52.960515653775 e-64 inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 52.960515653775
10007964 E-64c 76684-89-4 ≥98% 2006-08-02 50.887863720074 e-64c EP 475; Loxistatin Acid; NSC 694279 E-64 cysteine protease cell cycle inhibitor E-64d 50.887863720074
10111 EA4 - ≥95% 2005-10-12 12.514269211451 ea4 phospholipase A2 cPLA2 RBCs red blood cells CYP1A1 CYP1B1 cytochromes P450 cytosolic cow bovine human group IV quinones derivatives inhibits inhibition rPLA2 ionophore-induced ionophores arachidonic acids release calcium Ca2+-dependent Ca+2 mammalian mRNA proteins mouse murine hepatoma Hepa-1c1c7 MCF-7 Hep-G2 HL-60 12.514269211451
10005056 Eicosapentaenoic Acid-d5 145191-14-6 ≥99% deuterated product 2005-08-30 225.205591160221 eicosapentaenoic-acid-d5 EPA-d5; Timnodonic Acid-d5 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory 225.205591160221
9000295 Eicosapentaenoic Acid methyl ester New 2734-47-6 ≥98% 2011-10-07 41.882532228361 eicosapentaenoic-acid-methyl-ester EPA vascular cardiovascular diseases immunity resolvins autoimmunity nephritis glomerulonephritis inflammation anti-inflammatory resolutions prodrugs antiinflammatory anti inflammatory immune physiology resolvins pro-drugs hydrolyzed esterases cells EPAs 41.882532228361
10964 Eicosapentaenoyl Ethanolamide 109001-03-8 ≥98% 2011-06-22 40.016432517759 eicosapentaenoyl-ethanolamide EPEA cannabinoids CBSs endocannabinoids forensic sciences signals signaling N-acylethanolamide N-acylethanolamine NAE dietary restrictions lifespans TOR nematodes eicosapentaenoic acids inflammation anti-inflammatory 40.016432517759
10569 Ellagic Acid 476-66-4 ≥95% 2010-10-13 5.686273787600 ellagic-acid Lagistase; TBBD; Gallogen polyphenols, antioxidants, cancers inflammation cytochrome P450s CYP450 epigenetics genes expression histones modifications alizarin yellow G 91006 elagostasine 77415-21-5 124590-32-5 PRMTs inflammatory anti-carcinogenic anti-mutagenic organ-preserving antimutagenic antiinflammatory Acid Benzoaric Benzoaric Acid Acid Ellagic Ellagic Acid 5.686273787600
10477 EP2 Receptor Polyclonal PE Antibody - 2010-07-07 22.969714548802 ep2-receptor-polyclonal-pe-antibody Prostaglandin E2 Receptor 2; PGE2 Receptor 2 R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons 22.969714548802
600340 EP2 Receptor (rat) STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-09-20 21.438720073665 ep2-receptor-rat-step-reporter-assay-kit-luminescence Prostaglandin E2 Receptor 2; PGE2 Receptor 2 prostaglandins E2 PGE2 prostanoids G protein-coupled receptors GPCRs EP1 EP3 EP4 signal transduction tissues regulation cells mediates cAMP cyclic messenger pathways mucosal protection gastrointestinal secretions motility immunity inflammation mice mouse murine tumors cancers cancer-associated immunodeficiency dendritic-cell differentiation in vitro neuroprotective NMDA toxicity oxygen glucose deprivation agonists antagonists therapeutics Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening 21.438720073665
600410 EP4 Receptor (rat) STEP Plate Assay Kit (cAMP method) - 2011-06-28 6.808379373849 ep4-receptor-rat-step-plate-assay-kit-camp-method cell-based assays cells CBAs kits measures measurements prostaglandins E2 PGE2 prostanoids G protein-coupled receptors proteins GPCRs EP1 EP2 EP3 signals transductions mechanisms tissues localizations regulation expression intestines lungs kidneys thymus uterus brains cyclics AMP adenosines monophosphates pathways phosphatidylinositols 3-kinases G1 smooth muscles relaxation gastric secretions intestinal epithelial transportation adrenal aldosterone uterine immunity inflammation human colon cancers colorectal carcinogenesis in vivo neuroprotective excitotoxic injury injuries agonists antagonists therapeutics diseases surface transfections and expression protocols transient technology technologies University of Michigan UM U of M Originus, Inc. USPT United States patents 6897067 6902933 7056741 DNA deoxyribonucleic recombinant proteins cells receptor-mediated endocytosis solution-phase efficiency multiple plasmids constructs intracellular 6.808379373849
10008610 Epoxy Fluor 7 Exclusive 863223-43-2 ≥98% ✓ 2006-08-30 10.626194751380 epoxy-fluor-7 epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology 10.626194751380
10009798 EX-527 49843-98-3 ≥98% 2009-10-23 26.034929404543 ex-527 sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 26.034929404543
10009549 FABP4 (human recombinant) - >90% 2007-06-15 32.261976200594 fabp4-human-recombinant A-FABP; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4; aP2; Adipocyte Fatty Acid Binding Protein cytosolic fatty acids lipophilic ligands tissues uptake metabolism intracellular trafficking lipid FABP-4 metabolic pathways cell growth differentiation bidirectional flux insulin epinephrine adipocytes atherosclerosis endocrinology 32.261976200594
9001068 FABP4 (human recombinant) FITC conjugated New - ≥95% 2011-08-23 11.593022888713 fabp4-human-recombinant-fitc-conjugated ALBP; Adipocyte-Fatty Acid Binding Protein; A-FABP; FABP4 fatty acids adipocytes obesity insulin resistence sensitivity cardiovascular disease atherosclerosis inflammation FABP-4 11.593022888713
10010463 FABP4 (human recombinant) Western Ready Control - 2007-10-23 5.691125690607 fabp4-human-recombinant-western-ready-control A-FABP; FABP4; ALBP; Adipocyte-FABP; Fatty Acid Binding Protein 4 fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis endocrinology immunoblotting 5.691125690607
10005191 FABP4 (mouse recombinant) - >95% 2005-07-27 11.970839779005 fabp4-mouse-recombinant Adipocyte-FABP; ALBP; Fatty Acid Binding Protein 4; A-FABP protein-only protein-4 endogenous exogenous lipophilic ligands uptake metabolism intracellular trafficking lipid metabolic pathways modulation cell growth differentiation antiparallel .beta. strands barrel fat cells specific facilitate bidirectional flux insulin epinephrine proteins recombinant binding adipocytes fatty acids agonists insulin hyperinsulinemia deficiency afabp adipocytes atherosclerosis endocrinology 11.970839779005
10009676 FABP4 (mouse recombinant) Western Ready Control - 2007-04-30 6.356127992633 fabp4-mouse-recombinant-western-ready-control ALBP; Fatty Acid Binding Protein 4; Adipocyte-FABP; A-FABP fatty acids proteins western blots blotting WB binding proteins adipocytes atherosclerosis 6.356127992633
10610 F-Amidine (trifluoroacetate salt) Exclusive New - ≥95% ✓ 2011-09-23 17.411764701458 f-amidine-trifluoroacetate-salt proteins arginine deiminase 4 PAD4 cancers arthritis inhibitors histones genes expression cysteine PAD1 PAD3 cytotoxic HL-60 MCF7 HT-29 877617-46-4 PADs PAD-1 PAD-3 PAD-4 peptidyl arginine 17.411764701458
13563 FIPI Exclusive 939055-18-2 ≥98% ✓ 2010-03-24 27.400508287292 fipi 5-Fluoro-2-Indolyl des-Chlorohalopemide Phospholipases D PLD phosphatidic acids PA Ras activation cells spreading stress fiber formation chemotaxis membrane vesicles trafficking halopemide inhibitors inhibits inhibition PLD1 PLD2 F-actin cytoskeletons inflammation arthritis Pharmascience Brand of Domperidone Maleate Stadapharm Brand of Domperidone Maleate Ratiopharm Brand of Domperidone Maleate Taxandria Brand of Domperidone Maleate Novopharm Brand of Domperidone Maleate Nu-Pharm Brand of Domperidone Maleate Nu Pharm Brand of Domperidone Maleate Apotex Brand of Domperidone Maleate Hexal Brand of Domperidone Maleate Aliud Brand of Domperidone Maleate Teva Brand of Domperidone Maleate Pierre Fabre Brand of Domperidone Gry Brand of Domperidone Maleate Rottapharm Brand of Domperidone Monohydrochloride, Domperidone Domperidone Monohydrochloride Janssen Brand of Domperidone Domperidone Maleate (1:1) Maleate, Domperidone Domperidone Maleate Gamir Domperidona Stada Domperidon ratio-Domperidone ratio Domperidone Hexal Domperidon Domperidona Gamir Novo-Domperidone Novo Domperidone Domperidon Stada Domperidon Hexal PMS-Domperidone PMS Domperidone Domperidon-TEVA Domperidon TEVA Apo-Domperidone Apo Domperidone Nu-Domperidone Nu Domperidone Domperidon AL Domperidone Gastrocure Domperidon R-33,812 Nauzelin Motilium R-33812 R33,812 Péridys Domidon R33812 27.400508287292
10039 FR122047 (hydrate) - ≥98% 10.663865430150 fr122047-hydrate 130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis 10.663865430150
13254 FTY720 phenoxy-biotin Exclusive - ≥95% ✓ 2009-10-28 71.467928176796 fty720-phenoxy-biotin sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide 71.467928176796
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 25.697569060774 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 25.697569060774
10566 Garcinol New 78824-30-3 ≥95% 2011-10-25 13.150272438202 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 13.150272438202
10010622 Genipin 6902-77-8 ≥98% 2008-05-09 97.871961325967 genipin (+)-Genipin obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity 97.871961325967
10011356 Glycerophospho-N-Palmitoyl Ethanolamine Exclusive 100575-09-5 ≥98% ✓ 2009-03-12 10.309723756906 glycerophospho-n-palmitoyl-ethanolamine GP-NPEA; GP-NAE cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic 10.309723756906
13127 GW 4869 6823-69-4 ≥90% 2009-06-10 50.452836095763 gw-4869 inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 50.452836095763
10009162 GW 627368X Exclusive 439288-66-1 ≥96% ✓ 2007-05-14 21.942002762430 gw-627368x EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X 21.942002762430
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 35.513204419889 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 35.513204419889
10010410 GW 848687X 612831-24-0 ≥98% 2009-11-25 15.197071823204 gw-848687x Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X 15.197071823204
13345 GYY 4137 Exclusive 106740-09-4 ≥95% ✓ 2009-07-31 114.901140270104 gyy-4137 hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 114.901140270104
10009465 HDAC6 (human recombinant) - >80% 2007-06-14 35.512939733524 hdac6-human-recombinant GenBank Accession No. BC069243; Histone Deacetylase 6 HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 35.512939733524
10009466 HDAC9 (human recombinant) - >95% 2007-06-14 21.009529094375 hdac9-human-recombinant GenBank Accession No. NM 178423; Histone Deacetylase 9 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 21.009529094375
10006809 Heptanoyl thio-PC - ≥98% 2005-10-05 10.282458563536 heptanoyl-thio-pc sPLA2s substrates colorimetrics phospholipases thioesters analogs glycerophospholipids Ellman's reagent measurements activity diheptanoyl thio-PC ether-linked saturated C16 moiety sn-1 position modifications resistant PLA1 pig porcine pancreatic bee venom 10.282458563536
11512 HMGB1 Monoclonal Antibody (Clone IMG19N10B7) New - 2012-01-16 145.000000000000 hmgb1-monoclonal-antibody-clone-img19n10b7 High Mobility Group Protein B1; HMG1 high mobility groups proteins family DNA-binding domains inflammation mediators DNA nuclear bindings sterile infection-associated responses Toll-like receptor 4 TLR4 advanced glycation endproducts RAGE IHC immunohistochemistry Western blot blotting flow cytometry FC WB 145.000000000000
11514 HMGB1 Monoclonal Antibody (Clone IMG19N12A1) - 85.000000000000 hmgb1-monoclonal-antibody-clone-img19n12a1 High Mobility Group Protein B1; HMG1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 85.000000000000
11513 HMGB1 Monoclonal Antibody (Clone IMG19N15F4) New - 2012-01-16 145.000000000000 hmgb1-monoclonal-antibody-clone-img19n15f4 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear binding sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 145.000000000000
11515 HMGB1 Polyclonal Antibody (aa 100-150) New - 2012-01-20 148.333333333333 hmgb1-polyclonal-antibody-aa-100-150 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting flows cytometry FC immunohistochemistry IHC 148.333333333333
11516 HMGB1 Polyclonal Antibody (aa 25-75) New - 2012-01-30 156.666666666667 hmgb1-polyclonal-antibody-aa-25-75 HMG1; High Mobility Group Protein B1 high mobility groups proteins B1 HMGB family DNA-binding domains nuclei nucleus cytoplasm cells mediators inflammation DNA nuclear bindings sterile infection-associated responses Toll-like receptors 4 TLR4 advanced glycation endproducts RAGE WB Western blots blotting 156.666666666667
10888 HZ52 New 1077626-51-7 2011-09-30 18.943660547265 hz52 inhibitors inhibits inhibition 5-LO 5 LO 5LO leukotrienes LTBs LTB4 LTs leukocytes neutrophils inflammation shock HZ-52 HZ 52 18.943660547265
10676 I-BET Exclusive - ≥98% ✓ 2011-06-08 46.805541124523 i-bet GSK525762A BET proteins BRD2 BRD3 BRD4 inflammation genes expressions histones acetylation chromatins complexes bacteria sepsis lipopolysaccharides endotoxic shock BRD-2 BRD-3 BRD-4 inflammatory IBET 46.805541124523
13930 IKKγ Monoclonal Antibody (Clone 46B844) - 2010-10-20 16.917863720073 ikk-monoclonal-antibody-clone-46b844 NF-κB Essential Modulator; NEMO; IKK3 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots immunoblotting WB blotting flow cytometry FC intracellular 16.917863720073
13931 IKKγ Monoclonal Antibody (Clone 72C627) - 2010-11-08 18.121055862492 ikk-monoclonal-antibody-clone-72c627 NF-κB Essential Modulator; NEMO; IKK3 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ IKKg IKKγ IKKgamma IKK.gamma. IKK-g IKK-γ IKK-gamma IKK-.gamma. IKK g γ .gamma. gamma cytoplasm inhibitory inhibits inhibitions proteins mask nuclear localization signals translocation nucleus tumors necrosis factors cytokines phosphorylation degradation dimers translocates genes autoregulated auto regulated auto-regulated complex essentials modulators t-cells t cells tcells leukemia virus types 1 one taxes oncoprotein key molecule adapter onco-protein onco oncoprotein signalling signalin western blots WB blotting 18.121055862492
13929 IKKε Monoclonal Antibody (Clone 72B587) - 2010-10-20 16.917863720073 ikk-monoclonal-antibody-clone-72b587 TBK1; IKKi antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 16.917863720073
13928 IKKε Polyclonal Antibody - 2010-10-20 16.917863720073 ikk-polyclonal-antibody IKKi antibodies IKKe IKKε IKK e ε IKK-e IKK-ε IKKepsilon IKK epsilon IKK-epsilon IKK.epsilon. .epsilon. IKK-.epsilon. IκBα IkBa IκBa IkBα IκB-α IκB α antibodies IκBα IkBa IκBa IkBα IκB-α IκB α IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g IKK IKK1 IKK2 IKK1/α IKK-1/α 1/α IKK2/β IKK-2/β 2/β IKK3/γ IKK-3/γ 3/γ IKK1/.alpha. IKK2/.beta. IKK3/.gamma. IKK1/alpha IKK2/beta IKK3/gamma IKK-1/.alpha. IKK-2/.beta. IKK-3/.gamma. IKK-1/alpha IKK-2/beta IKK-3/gamma 1.alpha. 1alpha 1α 2.beta. 2beta 2β 3.gamma. 3gamma 3γ 1-.alpha. 1-alpha 1-α 2-.beta. -2beta 2-β 3-.gamma. 3-gamma 3-γ cytoplasm inhibitory inhibits inhibition proteins nuclear localization signals nucleus stimuli tumor necrosis factors sytokines phosphorylation degradation dimers subtracive hybridization technique novel kinases LPS mRNA levels mouse murine macrophage cells lines overexpression wild types phosphorylates Ser32 Ser36 Ser-32 Ser-36 Ser 32 36 16.917863720073
10809 Interleukin-33 (human) Monoclonal Antibody (Clone IL33305B) - 2011-06-03 0E-12 interleukin-33-human-monoclonal-antibody-clone-il33305b IL-1F11; NF-HEV; IL-33 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunohistochemistry IHC immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10811 Interleukin-33 Monoclonal Antibody (Clone IL33026B) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il33026b IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay immunoprecipitation IP IL 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10810 Interleukin-33 Monoclonal Antibody (Clone IL333068A) - 2011-06-02 0E-12 interleukin-33-monoclonal-antibody-clone-il333068a IL-33; NF-HEV; IL-1F11 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay 1F11 IL1F11 interleukin 33 NFHEV NF HEV 0E-12
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 23.657842234500 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 23.657842234500
13843 IRAK-1 Polyclonal Antibody - 2010-11-11 0E-12 irak-1-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase 1 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 receptors signaling cascase activation members novel cytokines IL-18 IL18 18 IGIF antibodies western blots blotting immunoblotting WB IP immunoprecipatation IRAK-1 0E-12
13844 IRAK-2 Polyclonal Antibody - 2010-11-18 0E-12 irak-2-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase-Like 2 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB serine threonine serine/threonine IL-1 IL1 IL 1 antibodies western blots blotting immunoblotting WB IL-1RI signaling cascade activation IRAK-2 IRAKs 2 pelle proteins kinases drosophila cytokine oligonucleotides inhibits inhibition IL-18 IL18 anti-sense antisense AP-1 AP1 APs 1 IRAK2 0E-12
13845 IRAK-4 Polyclonal Antibody - 2010-11-18 0.261444356748 irak-4-polyclonal-antibody Interleukin-1 Receptor-Associated Kinase-Like 4 NF-kB NF-κB NFkB NFκB NF kB NFκB NF-kappaB kappaB NFkappaB NF.kappa.B NF-.kappa.B .kappa.B nuclear factor κB antibodies toll-like toll like receptors interleukin-1 IL-1 IL1 IL TLRs mammal transmembranes trans membranes IRAKs TRAF6 TRAF-6 TRAFs 6 MyD88 MAPK pathways LPS activation murine viral bacterial antibodies western blots WB immunoblotting blotting immunoprecipitation IP IRAK4 0.261444356748
10739 Isoliquiritigenin 961-29-5 ≥98% 2011-04-01 36.586298342541 isoliquiritigenin ISL; GU 17 antioxidants flavonoids chemoprevention quinones reductase-1 reductase1 hepatoprotection hepatoma cells flavanoids 36.586298342541
13925 IκBα (cleavage specific) Monoclonal Antibody (Clone 5D1623) - 2010-09-29 10.216464088397 i-b-cleavage-specific-monoclonal-antibody-clone-5d1623 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target cleaved caspases caspase-3 3 apoptosis amino-terminal amino terminals truncated DN-IκBα DNIκBα DN ΔN-IκBα ΔN .DELTA.N DELTAN .DELTA.N-IκBα DELTAN-IκBα DELTA-N .DELTA.-N degradation inducers dominant inhibitory molecule suppresses activity inflammation 10.216464088397
13922 IκBα Monoclonal Antibody - biotin (Clone 6A920) - 2010-09-27 13.808488196886 i-b-monoclonal-antibody-biotin-clone-6a920 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular immunoblotting NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target ELISA biotinlated biotins 13.808488196886
13918 IκBα Monoclonal Antibody (Clone 6A920) - 2010-09-23 13.808488196886 i-b-monoclonal-antibody-clone-6a920 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α flow cytometry FC intracellular immunohistochemistry IHC paraffin-embedded sections paraffin embedded immunoprecipitation IP western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 13.808488196886
13924 IκBα (Phospho-Ser32/36) Monoclonal Antibody - biotin (Clone 39A1413) - 2010-09-29 0.140883977900 i-b-phospho-ser32-36-monoclonal-antibody-biotin-clone-39a1413 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser EIA ELISA biotins biotinylated inflammation genes regulation signal transduction 0.140883977900
13923 IκBα (Phospho-Ser32/36) Monoclonal Antibody (Clone 39A1413) - 2010-09-29 14.705022601707 i-b-phospho-ser32-36-monoclonal-antibody-clone-39a1413 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target immunoprecipitation IP serines serine32 serine36 serine-32 serine-36 32 36 ser32 ser36 ser-32 ser-36 ser genes regulation inflammation signal transduction 14.705022601707
13921 IκBα Polyclonal Antibody - 2010-09-23 0.140883977900 i-b-polyclonal-antibody antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB NF-κB NFκB NF κB slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 0.140883977900
13919 IκBα Polyclonal Antibody (aa 34-48) - 2010-09-23 13.808488196886 i-b-polyclonal-antibody-aa-34-48 antibodies IκBα IkBa IκBa IkBα IκB-α IκB α intracellular western blots blotting immunoblotting WB antibodies IκBα IkBa IκBa IkBα IκB-α IκB α slienced slience inhibitory inhibits inhibition inhibitor proteins asutoregulated auto-regulated auto regulated regulates phosphorylated kinase complex IKK IKK1 IKK2 IKK3 IKK-1 IKK-2 IKK-3 1 2 3 IKK1/a IKK1-a IKK1a IKK2/b IKK2-b IKK2b IKK3/g IKK3-g IKK3g degradation phosphorylation dimers translocates nucleus genes target 13.808488196886
9000059 (±)-Jasmonic Acid methyl ester 39924-52-2 ≥95% (mixture of isomers) 2009-04-01 4.355060773480 -jasmonic-acid-methyl-ester (±)-Methyl Jasmonate cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory 4.355060773480
10011925 JNJ-7777120 459168-41-3 ≥98% 2011-02-24 2.119060773480 jnj-7777120 histamines H4 receptors antagonists inflammation Piperazines 2.119060773480
10009018 JWH 015 155471-08-2 ≥98% 2006-10-05 69.456328567956 jwh-015 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 69.456328567956
10660 JWH 015-d7 Exclusive - ≥99% deuterated product ✓ 2011-02-21 48.804751381215 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 48.804751381215
9001148 Ketorolac New 74103-06-3 ≥98% 2012-01-12 119.952500066725 ketorolac Sprix®; Acular PF®; RS 37619; Acular LS® analgesic NSAIDs COX inhibition inhibits inhibitors ocular pain inflammation PGE2 non steroidal anti-inflammatory antiinflammatory drugs heteroaryl acetic acids derivatives cyclooxygenase opthalmalic solutions ocular COX-1 COX-2 COX1 COX2 racemic 66635-83-4 ± (±) 119.952500066725
10011565 L-161,982 147776-06-5 ≥98% 2009-02-26 57.124640883978 l-161-982 PGEs PGE2 EPs EP4 receptors antagonist bone formation inflammation cells proliferation colon cancers L161982 L-161982 57.124640883978
10007712 L-902,688 Exclusive 634193-54-7 ≥98% ✓ 2010-05-07 41.522896606156 l-902-688 PGE2 bones growth EP4 agonists hyperalgesia vasodialation 41.522896606156
10010329 Lavendustin C 125697-93-0 ≥98% 2008-07-08 13.433480662983 lavendustin-c HDBA; NSC 666251 EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition Lavendustin-C 13.433480662983
10006148 Leelamine 1446-61-3 >98% 2006-05-10 0.520865561694 leelamine Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.520865561694
10008614 Leelamine (hydrochloride) - >98% 2006-05-10 0.419208103131 leelamine-hydrochloride Dehydroabietylamine (hydrochloride) inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.419208103131
10007817 Leukotriene A4 Hydrolase (human recombinant) - >90% 2005-12-14 266.375604665439 leukotriene-a4-hydrolase-human-recombinant LTA4H leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis 266.375604665439
20110 Leukotriene B4 71160-24-2 ≥97% 185.740685732856 leukotriene-b4 LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis 185.740685732856
20114 Leukotriene B4-3-aminopropylamide 89596-43-0 ≥95% 2009-03-05 347.785138121546 leukotriene-b4-3-aminopropylamide LTB4-3-aminopropylamide LTB LTB4 BLTs BLT1 BLT2 inflammation immunology 347.785138121546
20112 Leukotriene B4 Ethanolamide - >97% 31.804656669297 leukotriene-b4-ethanolamide LTB4-EA BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines 31.804656669297
10007240 Leukotriene B4 Lipid Maps MS Standard 71160-24-2 ≥97% 2009-01-14 33.215038674032 leukotriene-b4-lipid-maps-ms-standard LTB4 leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards 33.215038674032
10006198 Leukotriene C4-d5 - ≥99% deuterated product 2007-04-11 99.425414364641 leukotriene-c4-d5 LTC4-d5 cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry 99.425414364641
10007692 Licofelone 156897-06-2 ≥98% 2006-04-03 64.351019030079 licofelone ML 3000 inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 64.351019030079
10011453 Lipoxin A5 Exclusive 110657-98-2 ≥95% ✓ 2008-11-17 56.639604051565 lipoxin-a5 LXA5 EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs 56.639604051565
10010785 (±)-Lisofylline 6493-06-7 ≥98% 2009-09-18 17.310372928177 -lisofylline CT-1501R; BL 194; LSF pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 17.310372928177
700570 L-Theanine Fluorometric Assay Kit Exclusive - ✓ 2011-05-31 242.092771639042 l-theanine-fluorometric-assay-kit 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins 242.092771639042
500260 Luminex® Leukotriene B4 Kit - 2008-11-12 28.486917127071 luminex-leukotriene-b4-kit Luminex® LTB4 Kit leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays 28.486917127071
10007502 Luminex® Thromboxane B2 Kit - 2009-07-13 30.788821362799 luminex-thromboxane-b2-kit Luminex® TXB2 Kit thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays 30.788821362799
10010024 LY223982 Exclusive 117423-74-2 ≥98% ✓ 2008-07-24 6.007845303868 ly223982 SKF 107324; CGS 23131 LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 6.007845303868
10009768 LY293111 Exclusive 161172-51-6 ≥98% ✓ 2009-02-09 90.572559852670 ly293111 Etalocib; VML 295 LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers 90.572559852670
10172 Lyso-PC 17364-16-8 >98% 2004-03-02 16.598262179809 lyso-pc lysopc signals transduction pathways G2A receptors lipids phosphatidylcholines phospholipases PLAs hydrolysis lysophosphatidic acid lysophosphatidyl choline LPA 16.598262179809
10010497 Manumycin A 52665-74-4 ≥98% 2008-06-25 20.587458563536 manumycin-a UCF 1C; NSC 622141 farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB 20.587458563536
13320 MCI-186 89-25-8 ≥98% 2010-07-15 25.652115232833 mci-186 NSC 2629; Edaravone free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries Ketoquinolines Oxoquinolines Quinolinones Quinolones strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone 25.652115232833
10639 MDA 77 Exclusive 1103774-21-5 ≥98% ✓ 2011-05-16 4.063591160221 mda-77 CB2 inverse agonists inflammation pain CB1 CBs cannabinoids peripheral MDA77 MDA-77 in vivo binds binding assay 4.063591160221
13847 MEK2 Polyclonal Antibody - 2010-11-18 0E-12 mek2-polyclonal-antibody MAP Kinase/ERK Kinase 2; MAPKK2; MAP Kinase Kinase 2; Dual Specificity MAP Kinase Kinase 2 MEKs MEK-2 MEK2 MAPKs kinases MAP ERKs phosphorylation antibodies serine cytokines growth factors tranduction mitogenic signals western blots blotting immunoblotting 0E-12
13848 MEKK2 Polyclonal Antibody - 2010-12-21 0E-12 mekk2-polyclonal-antibody MAP Kinase/ERK Kinase Kinase 2; Dual Specificity MAP Kinase Kinase Kinase 2; MAP Kinase Kinase Kinase 2; MAP3K2; MAPKKK2 MEKs MEK-2 MEK 2 MAPKs kinases MAPs mitogen-activated mitogen activated proteins signaling pathway phosphorylate IkB I.kappa.B IkappaB IκB NF-κB NF-kappaB NF-.kappa.B NFκB NF.kappa.B NFkB T-cells T cells cytokine genes expressions mast cells epidermal growth factor EGRs fibroblast growth factor-2 factor 2 FGF-2 FGF2 FGFs 2 signals rheumatoid arthritis LPS-TLR4 LPS TLR4 TLR-4 TLR 4 ligands phosphorylation western blots blotting immunoblotting WB immunohistochemistry IHC MAP kinase kinase kinase 0E-12
600160 Methionine Sulfoxide Immunoblotting Kit - 2009-12-17 210.098508287293 methionine-sulfoxide-immunoblotting-kit MetO Immunoblotting Kit proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 210.098508287293
10010252 Methyl-L-NIO (hydrochloride) 150403-96-6 >98% 2008-02-12 7.353508287293 methyl-l-nio-hydrochloride NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation 7.353508287293
500400 Mouse Anti-Type II Collagen IgG Assay Kit (Qualitative, bovine) New - 2011-10-14 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-bovine EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500420 Mouse Anti-Type II Collagen IgG Assay Kit (Qualitative, chick) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-qualitative-chick EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500410 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, bovine) New - 2011-10-14 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-bovine EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500430 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, chick) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-chick EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
500470 Mouse Anti-Type II Collagen IgG Assay Kit (Quantitative, mouse) New - 2011-10-17 0E-12 mouse-anti-type-ii-collagen-igg-assay-kit-quantitative-mouse EIAs enzymes kits assays measures measurements immunometric enzymes immunoassays collagen-induced arthritis CIA autoimmune diseases human rheumatoid RA pathogenic therapeutics mouse rat murine nonhuman primates immunization heterologous CII proteins articular cartilage autoimmune-mediated polyarthritis collagen-specific T cells antibody autologous inflammation cascade pro-inflammatory cytokines chemokines degrading Type II plasma serum 0E-12
10004910 Mouse Macrophage Microsomal Immunoblot Control - 2004-11-09 30.001810926949 mouse-macrophage-microsomal-immunoblot-control Mouse macrophage microsomes protein western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE 30.001810926949
13746 MyD88 Polyclonal Antibody - 2010-02-05 29.770497237569 myd88-polyclonal-antibody proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling 29.770497237569
10006438 Myeloperoxidase Chlorination Assay Kit - 2009-04-14 116.387803867403 myeloperoxidase-chlorination-assay-kit MPO Chlorination Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl 116.387803867403
700170 Myeloperoxidase Inhibitor Screening Assay Kit - 2009-04-14 93.619790055248 myeloperoxidase-inhibitor-screening-assay-kit MPO Inhibitor Screening Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays 93.619790055248
700160 Myeloperoxidase Peroxidation Assay Kit - 2009-04-14 107.839060773480 myeloperoxidase-peroxidation-assay-kit MPO Peroxidation Assay Kit heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 107.839060773480
10007704 N-(3-hydroxyphenyl)-Arachidonoyl amide Exclusive 183718-75-4 >98% ✓ 2007-02-02 17.586243093923 n-3-hydroxyphenyl-arachidonoyl-amide 3-HPAA neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic 17.586243093923
10008284 N-acetyl-2-carboxy Benzenesulfonamide Exclusive 849067-18-1 >98% ✓ 2006-05-10 15.092081031307 n-acetyl-2-carboxy-benzenesulfonamide analogs aspirin inhibits inhibitors inhibition cyclooxygenaes COX-1 COX-2 COX1 COX2 15.092081031307
11189 N-acetyl-Pro-Gly-Pro Peptide New - ≥95% by HPLC 2012-02-02 136.552744014733 n-acetyl-pro-gly-pro-peptide N-acetyl-PGP chemokines receptors ligands COPD cystic fibrosis neutrophils infiltration PMN chemoattractants CXC ECM PGP metabolites BAL bronchoalveolar inflammation inflammatory diseases 136.552744014733
579040 Nampt/Visfatin (mouse/rat) EIA Kit - 2011-08-08 33.384570606041 nampt-visfatin-mouse-rat-eia-kit Nicotinamide Phophoribosyltransferase/Visfatin Pre-B-Cell Colony-Enhancing Factor/Visfatin immunometric kits measures measurements EIA enzymes immunoassays nicotinamides phosphoribosyltransferases coenzymes salvage pathways adenine dinucleoties NAD+ cellular metabolisms pre-B-cell cells colony enhancing factors PBEF visceral fats plasmas obesity insulin receptors proteins intracellular extracellular mesangial kidneys glucose uptake diabetic nephropathy exercise skeletal muscles NAD+-dependant sirtuin-dependant circadian oscillations cancers apoptosis serums body mass index mass inflammation livers cirrhosis beta .beta. β leukocytes tissues mouse 33.384570606041
16841 NBD-FTY720 phenoxy (hydrochloride) - ≥96% 2009-08-04 68.467937384898 nbd-fty720-phenoxy-hydrochloride sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 fluorescent fluorescence FTY720-phosphates sphingosines immunosuppression immune modulators transporters cPLA2 cytosolic phospholipases A2 phosphorylation 68.467937384898
13570 N-Benzylacetamidine (hydrobromide) 186545-76-6 ≥98% 2010-02-11 30.698259668509 n-benzylacetamidine-hydrobromide NO nitric oxide synthases NOS iNOS inflammation immune responses eNOS inhibitors inhibits inhibition inflammatory alpha-D-N-Acetyl-Galactosaminyloligosaccharidase alpha D N Acetyl Galactosaminyloligosaccharidase alpha-D-N-Acetylgalactosaminyloligosaccharidase alpha D N Acetylgalactosaminyloligosaccharidase endo-N-Acetyl-alpha-D-Galactosamidase endo N Acetyl alpha D Galactosamidase endo-alpha-N-Acetylgalactosaminidase endo alpha N Acetylgalactosaminidase N-Acetyl-alpha-D-Galactosaminidase N Acetyl alpha D Galactosaminidase alpha-N-Acetyl-D-galactosaminidase alpha N Acetyl D galactosaminidase alpha-N-Acetylgalactosaminidase alpha N Acetylgalactosaminidase alpha-Galactosidase B alpha Galactosidase B 30.698259668509
10009818 NF-κB (p50) (human recombinant) - >75% 2007-06-20 45.372824585635 nf-b-p50-human-recombinant NF-κB1; Nuclear Factor-κB (p50) transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b 45.372824585635
13755 NF-κB (p50) Monoclonal Antibody (Clone 2J10D7) - 2010-02-05 11.177348066298 nf-b-p50-monoclonal-antibody-clone-2j10d7 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry 11.177348066298
13754 NF-κB (p50) Polyclonal Antibody - 2010-04-27 11.177348066298 nf-b-p50-polyclonal-antibody NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies 11.177348066298
10010184 NF-κB (p50) Western Ready Control - Whole cell lysate 2007-07-19 46.595224940805 nf-b-p50-western-ready-control Nuclear Factor-κB (p50); NF-κB1 western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals 46.595224940805
13756 NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021) - 2010-02-11 20.718358326756 nf-b-p65-monoclonal-antibody-biotin-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones 20.718358326756
13752 NF-κB (p65) Monoclonal Antibody (Clone 112A1021) - 2010-02-11 23.701783741120 nf-b-p65-monoclonal-antibody-clone-112a1021 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC 23.701783741120
13751 NF-κB (p65) NLS Polyclonal Antibody - 2010-02-11 21.821562746645 nf-b-p65-nls-polyclonal-antibody Nuclear Factor-κB (p65) Nuclear Localization Signal NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies 21.821562746645
13757 NF-κB (p65) Polyclonal Antibody (aa 2-17) - 2010-02-11 16.365951065509 nf-b-p65-polyclonal-antibody-aa-2-17 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 16.365951065509
13753 NF-κB (p65) Polyclonal Antibody (aa 538-546) - 2010-02-11 20.718358326756 nf-b-p65-polyclonal-antibody-aa-538-546 NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 20.718358326756
10006966 Nitrotyrosine Monoclonal Antibody - Biotinylated - 2005-04-15 17.547992633517 nitrotyrosine-monoclonal-antibody-biotinylated antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays 17.547992633517
13390 N-methyl Leukotriene C4 131391-65-6 >97% 2008-10-15 56.877384898711 n-methyl-leukotriene-c4 N-methyl LTC4 allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics 56.877384898711
10004971 N,N'-Dicyclohexylurea 2387-23-7 ≥98% 2010-03-17 16.225911602210 n-n-dicyclohexylurea DCU; NSC 17013 hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide Doms-Adrian Brand of Alanine Doms Adrian Brand of Alanine Alanine Doms-Adrian Brand Alanine, L-Isomer Alanine, L Isomer L-Isomer Alanine L-Alanine L Alanine Alanine Abufène 16.225911602210
10004942 Nod2 Monoclonal Antibody (Clone 2D9) - 2004-09-08 20.118953784091 nod2-monoclonal-antibody-clone-2d9 antisera antibody antibodies nod1 apoptosis nf kb nf-kb nf-.kappa.b nf-kappab crohn's diseases inflammations inflammatory bowel nod-2 nod-1 antiserum apoptosis caspases CARDs western blots blotting WB immunohistochemical immunohistochemistry IHC nfkb immunoblotting 20.118953784091
11040 Nodinitib-1 New 799264-47-4 ≥95% 2012-01-20 88.584858809084 nodinitib-1 ML130; CID-1088438 NOD1 NLR innate immunity NF-κB signaling inflammation MAPK inflammatory diseases inhibitors inhibition inhibits NACHT leucine proteins bacterial bacteria ligands stress kinases interferons polymorphisms genes asthma bowel multiple sclerosis MS cells CD83 CD86 HLA-DR IL-1β IL-6 TNFα 88.584858809084
10005705 NO-Indomethacin Exclusive 301838-28-8 >98% ✓ 2004-10-20 6.661988950277 no-indomethacin NCX 2121 inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic 6.661988950277
10010411 NS-304 475086-01-2 >98% 2008-04-09 39.701094532957 ns-304 ACT-293987; Selexipag prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs 39.701094532957
10011301 p38 MAPK Monoclonal Antibody (Clone 9F12) - 2008-05-22 2.238987108655 p38-mapk-monoclonal-antibody-clone-9f12 p38 Mitogen-activated Protein Kinase; p38 MAPKα serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC 2.238987108655
10784 PAD1 (human recombinant) - ≥95% 2011-05-12 17.192348066298 pad1-human-recombinant Protein-Arginine Deiminase 1 PAD1 PADI-1 arginine deiminase post-translational modifications citrullination skin keratinocytes calcium-dependent 17.192348066298
500930 PAD4 Autoantibody EIA Kit New - 2011-08-18 5.871944686553 pad4-autoantibody-eia-kit Protein Arginine Deiminase 4; Peptidylartginine Deaminase 4 peptidylarginine deiminase proteins arginines deiminases 4 guanidine guanidino-modifying enzymes amidinotransferases superfamily homodimers transcriptional coregulators catalyzes residues citrulline calcium-dependent rheumatoid arthritis RA arthritogenic autoantibodies citrullinated peptides cyclics CCP anti-CCP immunoassays immunometrics assays kits measures measurement isotypes IgM IgG IgA human plasmas serums 5.871944686553
10500 PAD4 (human recombinant) - ≥95% 2010-05-27 32.283646246770 pad4-human-recombinant Peptidylarginine Deiminase 4; Protein Arginine Deiminase 4 guanidino modifying enzymes citrillination histones deiminase MS multiple sclerosis Alzheimer's diseases glaucoma IOP intraocular pressure cancers peptidylarginine deiminase 32.283646246770
10279 PAF Acetylhydrolase (human recombinant) - ≥95% 2008-06-19 28.563906866613 paf-acetylhydrolase-human-recombinant Lp-PLA2; PAF-AH; Platelet-Activating Factor Acetylhydrolase; Lipoprotein PLA2 proteins PAFs lipids mediator inflammation PAFAH enzymes PAF AH phospholipases PLA2s inflammatory N-terminal His-tags His-tagged 28.563906866613
10010081 PAF Acetylhydrolase (human) Western Ready Control - 2007-05-30 5.625082872928 paf-acetylhydrolase-human-western-ready-control PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase; Lipoprotein PLA2 western blotting WB atherosclerosis factors asthma inflammation PAFs 5.625082872928
360900 PAF C-16-d4 - ≥99% deuterated product 21.294033149171 paf-c-16-d4 Platelet-activating Factor C-16-d4 PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis 21.294033149171
10010521 Palmitoyl thio-PC 113881-60-0 ≥98% 2008-05-23 14.835676795580 palmitoyl-thio-pc thioesters PLA2s substrates sPLA2 cPLA2 sn-2 analogs absorbance micelle systems 14.835676795580
10992 PAX5 Polyclonal Antibody New - 2011-12-06 34.444444444444 pax5-polyclonal-antibody BSAP transcription factors B cells development IL-7 phosphorylated STAT5 Western blots blotting WB IL7 IL 7 STAT-5 STAT 5 PAX-5 PAX 5 34.444444444444
10010907 PF-622 898235-65-9 >98% 2008-03-26 10.122044198895 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 10.122044198895
10010908 PF-750 959151-50-9 >98% 2008-03-25 14.324050414364 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 14.324050414364
13454 PGDM New 133161-96-3 ≥90% (mixture) 2012-02-02 160.857801455757 pgdm Prostaglandin D Metabolite PGD-M urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous 160.857801455757
11344 PGDM-d4 New - ≥99% deuterated forms (d1-d4) 2012-02-02 160.857801455757 pgdm-d4 Prostaglandin D Metabolite-d4 PGD-M deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry urine PGD2 prostaglandins D2 PGs metabolites urinary side chains cyclization biomarkers endogenous 160.857801455757
500290 Phagocytosis Assay Kit (IgG FITC) - 2009-04-09 153.570073664824 phagocytosis-assay-kit-igg-fitc kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba 153.570073664824
600540 Phagocytosis Assay Kit (IgG PE) New - 2012-01-10 164.042345764272 phagocytosis-assay-kit-igg-pe kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based cell based cba phycoerythrins probes fluorescence 164.042345764272
10009210 PIK-75 372196-67-3 ≥98% 2010-03-10 21.638544796614 pik-75 p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g Mixtures, Sulfonamide Sulfonamide Mixtures Sulfonamides 21.638544796614
13368 Piroxicam 36322-90-4 ≥95% 2010-01-06 19.599678383644 piroxicam NSC 666076; Larapam; Feldene inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory Piroxicam CP-16171 CP 16171 Feldene CP16171 19.599678383644
11004 Podoplanin Monoclonal Antibody (Clone NZ-1.2) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-nz-1-2 Aggrus; gp38; T1A mucin glycoproteins T1A gp38 aggrus tumors cells ligands CLEC-2 metastases tissues Th17 CD4+ humans PBMC antibodies 0E-12
11005 Podoplanin Monoclonal Antibody (Clone pmab-1) - 2011-08-05 0E-12 podoplanin-monoclonal-antibody-clone-pmab-1 Aggrus; gp38; T1A gp38 glycoproteins tissues lymphatic endothelial cells tumors lymphangiogenesis Th17 autoimmune diseases antibodies myelin antigens migration inflammation 0E-12
10007685 PPARγ FP-Based Ligand Screening Assay Kit - Green - 2009-07-16 42.093284781517 ppar-fp-based-ligand-screening-assay-kit-green Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists 42.093284781517
13327 PPM-18 65240-86-0 ≥95% 2010-09-15 8.936933701657 ppm-18 NSC 73233 inhibitors inhibits inhibition NF-κB NFκB NF κB NF-kB NFkB kB iNOS inflammation sepsis inducible nitric oxides synthases inflammatory NO Naphthalenediones Naphthoquinones Naphthazarins 8.936933701657
10006973 Pravadoline 92623-83-1 ≥98% 2011-02-08 53.944502841132 pravadoline WIN 48,098 Anti-inflammatory analgesic COX inhibitors pain AAI NSAIDs inhibits inhibition prostaglandins PGs synthesis murine inhibited mouse cyclooxygnases opoid Indoles receptors WIN48098 WIN-48098 WIN 48098 WIN-48,8098 53.944502841132
500940 Progranulin (human) EIA Kit - 2011-04-26 29.033164518108 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 29.033164518108
500950 Progranulin (mouse) EIA Kit - 2011-04-26 37.855111975081 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 37.855111975081
11188 Prolyl-glycyl-proline Peptide New - ≥95% by HPLC 2012-02-02 136.552744014733 prolyl-glycyl-proline-peptide PGP LTA4 hydrolases substrates COPD cystic fibrosis neutrophils infiltration CF MMP-8 MMP-9 CXCR1 CXCR2 chemoattractants 136.552744014733
10011724 Propenyl-L-NIO (hydrochloride) Exclusive - >90% ✓ 2008-08-19 5.523176795580 propenyl-l-nio-hydrochloride ENIPO nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition 5.523176795580
11510 Prostaglandin Bx Exclusive 39306-29-1 Mixture of oligomers ✓ 30.257734806630 prostaglandin-bx PGBx PGBx free radicals antioxidants prostaglandins 30.257734806630
512031 Prostaglandin D2 EIA Kit - 2010-07-19 283.645704419890 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 283.645704419890
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 129.804781130471 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 129.804781130471
10006593 Prostaglandin D Synthase (hematopoietic-type; human recombinant) - ≥95% 2005-02-16 33.738914759274 prostaglandin-d-synthase-hematopoietic-type-human-recombinant Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators 33.738914759274
10009625 Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control - 2007-07-19 24.196961325966 prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control Hematopoietic-PGDS; H-PGDS western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli 24.196961325966
10004347 Prostaglandin D Synthase (hematopoietic-type; mouse recombinant) Exclusive - ≥85% ✓ 2008-06-05 31.789214241866 prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant H-PGDS; Hematopoietic-PGDS PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS 31.789214241866
10006595 Prostaglandin D Synthase Inhibitor Screening Assay Kit - 2005-08-31 48.291376611417 prostaglandin-d-synthase-inhibitor-screening-assay-kit PGDS Inhibitor Screening Assay Kit prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS 48.291376611417
10006788 Prostaglandin D Synthase (lipocalin-type; human recombinant) - ≥95% 2005-03-23 39.011883714811 prostaglandin-d-synthase-lipocalin-type-human-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 39.011883714811
10009741 Prostaglandin D Synthase (lipocalin type; human) Western Ready Control - 2007-04-30 6.259475138121 prostaglandin-d-synthase-lipocalin-type-human-western-ready-control L-PGDS; Lipocalin-PGDS GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS 6.259475138121
10006787 Prostaglandin D Synthase (lipocalin-type; mouse recombinant) - ≥95% 2005-03-23 40.772154696132 prostaglandin-d-synthase-lipocalin-type-mouse-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds 40.772154696132
10010548 Prostaglandin D Synthase (lipocalin-type; rat recombinant) Exclusive - ≥95% ✓ 2008-07-01 37.585971100722 prostaglandin-d-synthase-lipocalin-type-rat-recombinant L-PGDS; Lipocalin-PGDS prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds 37.585971100722
14010 Prostaglandin E2 363-24-6 ≥99% 229.381540578316 prostaglandin-e2 PGE2; Dinoprostone PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 229.381540578316
514018 Prostaglandin E2 Affinity Purification Kit (20 ml) - 244.241165745856 prostaglandin-e2-affinity-purification-kit-20-ml PGE2 Affinity Purification Kit PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies 244.241165745856
500450 Prostaglandin E2 Affinity Purification Kit (4 ml) - 2010-07-28 190.863989739542 prostaglandin-e2-affinity-purification-kit-4-ml PGE2 PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies 190.863989739542
10581 Prostaglandin E2-d9 - ≥99% deuterated product 2010-09-16 92.460382136279 prostaglandin-e2-d9 PGE2-d9; Dinoprostone-d9 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards 92.460382136279
514010 Prostaglandin E2 EIA Kit - Monoclonal - 1732.986522685418 prostaglandin-e2-eia-kit-monoclonal PGE2 EIA Kit - Monoclonal; Prostaglandin E2 ELISA Kit - Monoclonal solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays PGE2 1732.986522685418
500141 Prostaglandin E2 Express EIA Kit - 517.708480662983 prostaglandin-e2-express-eia-kit PGE2 Express EIA Kit; Prostaglandin E2 Express ELISA Kit solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays 517.708480662983
500501 Prostaglandin E2 FPIA Kit - Green - 142.907694904849 prostaglandin-e2-fpia-kit-green PGE2 Fluorescence Polarization Immunoassay - Green kitrecommendation:pge2 metabolites EP1 EP2 EP3 EP4 prostaglandins immunoassays HTS fluorescent high-throughput kits screenings fluorescence fluorometric assays 142.907694904849
10384 Prostaglandin E2 isopropyl ester Exclusive 71845-66-4 ≥98% ✓ 2010-06-07 323.110734017363 prostaglandin-e2-isopropyl-ester PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic 323.110734017363
10007211 Prostaglandin E2 Lipid Maps MS Standard 363-24-6 >99% 2008-11-05 13.458621086556 prostaglandin-e2-lipid-maps-ms-standard Dinoprostone; PGE2 PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS 13.458621086556
10007939 Prostaglandin E Synthase-1 (microsomal) (human recombinant) - 16,000 x g supernatant 2009-03-15 24.408416206262 prostaglandin-e-synthase-1-microsomal-human-recombinant Membrane-Associated PGES-1; Prostaglandin H/E Isomerase; PIG12; mPGE Synthase-1; MGST1-L1 enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 24.408416206262
10009734 Prostaglandin E Synthase-1 (microsomal) Western Ready Control - 2007-05-01 8.333570441988 prostaglandin-e-synthase-1-microsomal-western-ready-control mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1 western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 8.333570441988
10010498 Prostaglandin E Synthase (cytosolic) (human recombinant, inactive protein) - 22.3 kDa (His-tagged); 18 kDa (native) 2008-01-22 3.510751381215 prostaglandin-e-synthase-cytosolic-human-recombinant-inactive-protein Hsp90 Co-chaperone; p23; Telomerase-binding protein p23; cPGE Synthanse; cPGES cPGES cPGE synthases telomerase-binding proteins p23 Hsp90 cochaperone PGES cytosolic enzymes 3.510751381215
10009735 Prostaglandin E Synthase (cytosolic) Western Ready Control - 2007-04-02 9.716320441988 prostaglandin-e-synthase-cytosolic-western-ready-control cPGES; cPGE Synthase; p23; Hsp 90 Co-chaperone; Telomerase-binding protein p23 telomerase-binding protein p23 blotting blots western WB glutathione dependent enzymes pges 9.716320441988
10009746 PTEN (human recombinant) - ≥95% 2008-09-04 7.611226519336 pten-human-recombinant TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10 proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged 7.611226519336
10009747 PTEN Western Ready Control - 2007-05-30 0E-12 pten-western-ready-control TEP1; MMAC1; Phosphoinositide 3-Phosphatase; Phosphatase and Tensin Homology on Chromosome 10 western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology 0E-12
13000 Pterostilbene 537-42-8 ≥98% 2009-09-09 32.300789265982 pterostilbene 3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory 32.300789265982
10009594 Pyocyanin 85-66-5 >98% 2007-07-12 32.469668508287 pyocyanin Pyocyanine; Sanazin; Sanasin Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis 32.469668508287
13294 Pyrrophenone 341973-06-6 ≥90% 2010-04-07 51.636966665119 pyrrophenone phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory Pyrrolidines 51.636966665119
10006734 QNZ 545380-34-5 >98% 2005-12-16 40.659053867403 qnz CAY10470 inhibits inhibitor inhibition NF kB NF-kB NF-.kappa.B nuclear factors transcription proinflammatory cytokines TNFa TNF.alpha. interleukins IL-1b IL-1.beta. IL-6 IL-8 activation Jurkat cells LPS lipopolysaccharides murine splenocytes in vivo edema carrageenin rat hind paw NF-kappaB nfkb nf-kb NF-.kappa.B 40.659053867403
10006045 (R)-Butaprost (free acid) - >98% 2004-11-09 20.735455801104 -r-butaprost-free-acid 15-deoxy-16R-hydroxy-17-cyclobutyl PGE1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1 PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers 20.735455801104
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 265.467516881522 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 265.467516881522
500380 Resolvin D1 EIA Kit New - 2012-01-13 182.177545621965 resolvin-d1-eia-kit RvD1 EIA ELISAs enzymes immunoassays kits measures measurements resolvins lipids mediators eicosapentaenoic acids EPAs docosahexaenoic DHA inflammation non-inflamed state oxygenation oxygenated 15-lipoxygenase 5 lipoxygenase 15-LO 5-LO 17(R)-RvD1 17(R) epimers aspirin-treatments configurations humans polymorphonuclear leukocytes PMNL transendothelial migrations acute aspirin-triggered murine mouse mice rat model peritonitis inhibition inhibits inhibitors adjuvant-induced arthritis antihyperalgesic effects prevents attenuates post-operative pains transient receptors potentials TRP channels TRPA1 TRPV3 TRP4 anti-nociceptives phagocytes ALX GPR32 insulin sensitivity leptins (db/db) pro-inflammatory macrophages adipose tissues 182.177545621965
10007279 Resolvin D2 Exclusive 810668-37-2 ≥95% ✓ 2010-06-25 148.173206905823 resolvin-d2 7(S),16(R),17(S)-Resolvin D2 EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis Docosahexaenoic Acid 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-(All-Z-Isomer) Docosahexaenoic Acid 4,7,10,13,16,19-Isomer Docosahexaenoic Acid 3,6,9,12,15,18-Isomer Docosahexaenoic Acid Dimer (All-Z Isomer) Docosahexaenoic Acid (All-Z Isomer) Acids Docosahexaenoic Docosahexaenoic Acids Acids Docosahexenoic Docosahexenoic Acids Docosahexaenoic Acid Docosahexaenoate 148.173206905823
13832 Resveratrol 3-O-D-Glucuronide 387372-17-0 ≥95% 2010-04-02 12.651933701657 resveratrol-3-o-d-glucuronide 1028964-58-0 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 12.651933701657
13900 Resveratrol-3-O-Sulfate 553662-69-4 ≥98% 2011-06-01 27.446250986582 resveratrol-3-o-sulfate polyphenol phytoalexin biochemicals physiological actions estrogenic antiplatelet anti-inflammatory piceid polydatin grape juices glucuronidated metabolites humans 27.446250986582
13833 Resveratrol 4'-O-D-Glucuronide 387372-20-5 ≥95% 2010-04-02 12.651933701657 resveratrol-4-o-d-glucuronide 3,5,4’-Trihydroxy-trans-Stilbene selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins AHR antagonists aryl hydrocarbon receptors 12.651933701657
13616 (R)-Lisofylline 100324-81-0 ≥98% 2010-05-27 1.784944751381 -r-lisofylline (R)-LSF; (-)-Lisofylline pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma 1.784944751381
13697 (R)-MG132 Exclusive 1211877-36-9 ≥98% ✓ 2010-06-22 91.533093922651 -r-mg132 ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited 91.533093922651
10011132 Rolipram 61413-54-5 ≥98% 2008-12-16 11.364248004910 rolipram ZK 62711; SB 95952 inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss 11.364248004910
13343 RSC-3388 337307-06-9 ≥95% 2010-02-15 11.150023155671 rsc-3388 cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis acrylamides 11.150023155671
10009227 (R)-SLV 319 656827-86-0 >98% 2007-09-05 0.216408839779 -r-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation 0.216408839779
13628 Salidroside 10338-51-9 ≥97% 2010-05-28 13.386206261510 salidroside Rhodioloside glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis Glucosides 13.386206261510
10951 Sampling Tubes with Indomethacin - 2011-06-01 0E-12 sampling-tubes-with-indomethacin spi-bio spibio COX inhibitors ex-vivo thromboxane B2 TXB2 PGs prostagandins cyclooxygenase anticoagulant sampling tubes blood metabolites 0E-12
13336 SB 225002 182498-32-4 ≥95% 2009-07-08 41.543729281767 sb-225002 CXCR2 IL-8RB IL-8 CXCL8 Gro-α CXCL1 inflammation chemokines neutrophils angiogenesis inhibitors colitis chemotaxis IL8 IL8RB Groα inhibition inhibits sb225002 41.543729281767
10010744 SC-51322 146032-79-3 >98% 2010-03-09 14.171624309391 sc-51322 SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist Misoprostol, (11alpha,13Z)-(+-)-Isomer Misoprostol, (11beta,13E)-(+-)-Isomer Misoprostol (11alpha.13E,16S)-Isomer Misoprostol (11alpha,13E,16R)-Isomer Misoprostol, (11beta,13E,16S)-Isomer Misoprostol, (11beta,13E,16R)-Isomer Misoprostol (11alpha,13E)-Isomer Grunenthal Brand of Misoprostol Novopharm Brand of Misoprostol Misoprostol Grunenthal Brand Pfizer Brand of Misoprostol Misoprostol Novopharm Brand Apotex Brand of Misoprostol Misoprostol Pfizer Brand Misoprostol Apotex Brand Novo-Misoprostol Novo Misoprostol Apo-Misoprostol Apo Misoprostol Misoprostol SC-30249 SC-29333 SC 30249 SC 29333 SC30249 SC29333 Cytotec Glefos 14.171624309391
10010267 SC-514 354812-17-2 ≥98% 2009-08-07 34.245933701657 sc-514 SC514 SC 514 inhibitors inhibits inhibitions IκB kinase IkB IKK2 NF-κB NFκB IL-1β IL1β genes expressions IL-6 IL6 IL-8 IL8 COX-2 COX2 iNOS LPS smooth muscles cells TLR2 TNF astrocytes 34.245933701657
70655 SC-58125 162054-19-5 >98% 19.013301104972 sc-58125 selective inhibitors inhibits COX-2 cox2 pghs2 pghs-2 prostaglandin synthases synthase-2 sc58125 cyclooxygenases diaryl heterocycles time-dependent 19.013301104972
13617 (S)-Lisofylline Exclusive 100324-80-9 ≥98% ✓ 2010-05-27 1.493646408840 -s-lisofylline (S)-LSF; (+)-Lisofylline pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed 1.493646408840
10009226 (±)-SLV 319 Exclusive 362519-49-1 >98% ✓ 2007-01-16 23.215648108797 -slv-319 CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic 23.215648108797
10012628 (S)-MG132 133407-82-6 ≥98% 2009-02-18 190.471049723756 -s-mg132 Z-Leu-Leu-Leu-CHO ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132 mg-132 2-LLL-CHO 190.471049723756
13121 Sodium Butyrate 156-54-7 ≥95% 2009-07-31 81.599160220994 sodium-butyrate Butyric Acid (sodium salt) fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg 81.599160220994
10012555 Sodium Hydrogen Sulfide (hydrate) 207683-19-0 ≥65% 2009-09-03 27.867152308846 sodium-hydrogen-sulfide-hydrate Sodium Hydrosulfide; NSC 158264; NaHS hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 27.867152308846
10011669 Soluble Epoxide Hydrolase (human recombinant) - ≥95% 2008-07-02 20.451292817679 soluble-epoxide-hydrolase-human-recombinant CEH; Cytosolic Epoxide Hydrolase; sEH; Epoxide Hydrolase 2; EPHX2 recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis 20.451292817679
10011671 Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit - 2009-02-24 23.239996419071 soluble-epoxide-hydrolase-inhibitor-screening-assay-kit sEH Inhibitor Screening Assay Kit epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions 23.239996419071
10011670 Soluble Epoxide Hydrolase (mouse recombinant) Exclusive - ≥95% ✓ 2008-07-01 5.204795580110 soluble-epoxide-hydrolase-mouse-recombinant sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278 5.204795580110
10010146 Soluble Epoxide Hydrolase Polyclonal Antibody - 2008-03-03 7.072434189145 soluble-epoxide-hydrolase-polyclonal-antibody Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH) metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting 7.072434189145
10010466 SP 600125 129-56-6 ≥98% 2009-01-07 12.446795580111 sp-600125 1PMV; Pyrazolanthrone; NSC 75890 c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125 12.446795580111
10008012 SPD-304 Exclusive 869998-49-2 >98% ✓ 2006-08-07 20.532348066298 spd-304 TNF-.alpha. TNF.alpha. signal transduction inflammation small-molecule inhibitor cytokine apoptosis NF-kB AP-1 inhibitor antagonist SPD304 SPD 304 CAY10500 CAY 10500 SPD00000304 SPD 00000304 20.532348066298
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 36.810628781899 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 36.810628781899
10348 Sphingosine Kinase 1 (human recombinant) - ≥90% by SDS-PAGE 2011-04-12 45.671961325967 sphingosine-kinase-1-human-recombinant SPHK1; SK1 sphingosines phosphates ceramides apoptosis acids cells death kinases sphingomyelin growth calcium 45.671961325967
10012201 Sphingosine Kinase 1 Polyclonal FITC Antibody Exclusive - ✓ 2008-06-06 7.499516574585 sphingosine-kinase-1-polyclonal-fitc-antibody SPHK 1 SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting 7.499516574585
10009237 Sphingosine Kinase 2 (human recombinant) - >80% by SDS-PAGE 2007-01-18 31.746523283346 sphingosine-kinase-2-human-recombinant SPHK 2; SK2 signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases 31.746523283346
10009563 sPLA2 (human recombinant Type V) - >95% 2007-01-16 50.004211172498 spla2-human-recombinant-type-v Secretory Phospholipase A2 (Group V); gVPLA2 proteins binding enzymes secretory phospholipases recombinant E. coli catalyzes hydrolysis fatty acids sn-2 glycerophospholipids isoforms arachidonic mobilization macrophages mast cells golgi apparatus nuclear envelope plasma membranes murine bone marrow-derived rat mouse heart lung placenta spleen P388D1 electrophoresis coomassie staining 50.004211172498
10011382 sPLA2 (human Type IIA) Western Ready Control Exclusive - ✓ 2008-03-17 31.066172059984 spla2-human-type-iia-western-ready-control Secretory Phospholipase A2 (human Type IIA); sPLA2 (human synovial) WB western blots blotting immunoblotting 31.066172059984
10009739 sPLA2 (human type V) Western Ready Control - 2007-05-25 18.048146101903 spla2-human-type-v-western-ready-control sPLA2 (group V); gVPLA2 western blotting WB controls antibodies antisera antiserum phospholipases sPLA2s group secretory monoclonal 18.048146101903
10922 SR 1001 - ≥98% 2011-06-28 84.077306683999 sr-1001 inflammation autoimmune diseases RORα RORγ retinoic-acid-receptor-related orphans receptors IL-17 TH17 cells ligands mutiple sclerosis MS agonists differentiation PBMCs inhibits inhibitors inhibition splenocytes NCoR SR1001 SR-1001 84.077306683999
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 73.523807550644 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 73.523807550644
10009022 (S)-SLV 319 Exclusive 464213-10-3 >98% ✓ 2007-08-16 0.216408839779 -s-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands 0.216408839779
10846 STAT1α/β Polyclonal Antibody - 2011-05-31 0E-12 stat1-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcriptions factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT1alpha/beta STAT1 alpha/beta signaling signalling STAT 1 STAT-1 STAT1a/b 0E-12
10847 STAT2 Polyclonal Antibody - 2011-05-31 0E-12 stat2-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-2 STAT 2 signaling signalling 0E-12
10861 STAT3 (Phospho-Tyr705) Polyclonal Antibody - 2011-05-31 0E-12 stat3-phospho-tyr705-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-3 STAT 3 signaling signalling 0E-12
10856 STAT5β Polyclonal Antibody - 2011-05-31 0E-12 stat5-polyclonal-antibody Signal Transducers and Activators of Transcriptions transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT5beta STAT5 signaling signalling STAT 5 STAT-5 0E-12
10931 STAT6 Polyclonal Antibody - 2011-07-13 0E-12 stat6-polyclonal-antibody Signal Transducers and Activators of Transcription 6; IL-4 STAT transcription factors genes expressions growth TNFR-1 TNFR1 apoptosis WBs western blots blotting immunoblotting STAT-6 STAT 6 signaling signalling 0E-12
10007207 tetranor-12(S)-HETE 121842-79-3 ≥98% 2005-12-07 35.040184162062 tetranor-12-s-hete neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology 35.040184162062
13369 tetranor-PGAM New 52510-53-9 ≥98% 2011-12-15 95.432980227081 tetranor-pgam tetranor-Prostaglandin A Metabolite tetranor-PGEM PGE2 urine metabolites prostaglandins E2 biomarkers inflammation diseases therapeutic metabolism biosynthesis tetranor PGAM tetranorPGAM PGA-M PGE-M 95.432980227081
12850 tetranor-PGDM Exclusive - ≥90% ✓ 2008-04-08 89.245104647383 tetranor-pgdm tetranor-Prostaglandin D Metabolite metabolites urinary PGD2 prostaglandins D2 urine PGD-M 89.245104647383
501001 tetranor-PGDM EIA Kit Exclusive - ✓ 2009-06-15 78.646920273174 tetranor-pgdm-eia-kit tetranor-Prostaglandin D Metabolite ELISA Kit solid plates prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays PGD-M 78.646920273174
13564 tetranor-PGDM lactone New - ≥90% 2012-01-19 151.867684468999 tetranor-pgdm-lactone tetranor-Prostaglandin D Metabolite lactone urine PGD2 prostaglandins D2 tetranor PGDM PGs allergic allergy asthma anaphylaxis sleep body temperature inhibits inhibition inhibitor platelets aggregation vascular smooth muscles urinary metabolites humans mouse biomarkers biosynthesis lactones PGD-M 151.867684468999
10522 Thapsigargin New 67526-95-8 ≥97% 2011-09-23 62.429183331396 thapsigargin calcium, ATPases, sarco/endoplasmic calcium ATPases SERCAs cells signaling activation histamine cancers tumorigenesis inflammation reticula sarcoplasmic endoplasmic 62.429183331396
70480 Tolfenamic Acid 13710-19-5 >99% 5.959511970533 tolfenamic-acid Clotam cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits calcium influx 5.959511970533
11111 Toll-Like Receptor 10 Monoclonal Antibody (Clone 3C10C5) New - 2011-11-18 14.777191807578 toll-like-receptor-10-monoclonal-antibody-clone-3c10c5 TLR10; CD290 TLRs innate immune systems transmembrane proteins cells patterns recognition receptors PRRs pathogen-associated molecular PAMPs signaling TIR domains Flow cytometry FC TLR10 TLR-10 14.777191807578
13582 Toll-Like Receptor 1 Polyclonal Antibody - 2009-10-10 1.392666572224 toll-like-receptor-1-polyclonal-antibody TLR1 antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins 1.392666572224
700240 Total Phosphatidic Acid Assay Kit - 2009-08-24 66.333977900552 total-phosphatidic-acid-assay-kit PA Assay Kit assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin 66.333977900552
11120 TPPU Exclusive New 1222780-33-7 ≥98% ✓ 2011-10-26 7.746896778076 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 7.746896778076
10012559 TP Receptor (human) Polyclonal FITC Antibody - 2008-07-25 76.878041743401 tp-receptor-human-polyclonal-fitc-antibody TXA2 Receptor; Thromboxane A2 Receptor antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IF immunofluorescence western blots blotting WB immunoblotting 76.878041743401
10855 TRAF2 Monoclonal Antibody (Clone 33A1293) - 2011-05-06 0E-12 traf2-monoclonal-antibody-clone-33a1293 TRAF 2 TRAF-2 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 0E-12
10872 TRAF3 Polyclonal Antibody - 2011-05-26 1.282707182320 traf3-polyclonal-antibody TRAF 3 TRAF-3 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.282707182320
10873 TRAF5 Monoclonal Antibody (Clone 55A219) - 2011-05-26 1.282707182320 traf5-monoclonal-antibody-clone-55a219 TRAF 5 TRAF-5 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.282707182320
10894 TRAF6BP Polyclonal Antibody - 2011-05-26 1.282707182320 traf6bp-polyclonal-antibody T6BP; TAX1BP1; TRAF6 Binding Protein; TAX1-binding protein TRAF 6BP TRAF-6BP WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.282707182320
10874 TRAF6 Polyclonal Antibody - 2011-05-26 1.282707182320 traf6-polyclonal-antibody TNF Receptor-Associated Factor 6 TRAF 6 TRAF-6 WBs western blots TNF tumors necrosis antibodies signal transduction proteins blotting immunoblotting 1.282707182320
13044 Tranilast 53902-12-8 ≥98% 2008-08-29 76.988364640884 tranilast SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF 76.988364640884
70675 trans-Resveratrol 501-36-0 >98% 96.284525582512 trans-resveratrol (E)-Resveratrol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes AHR antagonists aryl hydrocarbon receptors 96.284525582512
13130 trans-Resveratrol-d4 - ≥99% deuterated product 2009-01-14 19.032016574585 trans-resveratrol-d4 (E)-Resveratrol-d4 selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins AHR antagonists aryl hydrocarbon receptors 19.032016574585
10188 trans-trismethoxy Resveratrol 22255-22-7 >98% 2004-03-03 20.882596685083 trans-trismethoxy-resveratrol (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy AHR antagonists aryl hydrocarbon receptors 20.882596685083
13129 trans-trismethoxy Resveratrol-d4 - ≥99% deuterated product 2009-02-09 17.269631675874 trans-trismethoxy-resveratrol-d4 (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4 deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins AHR antagonists aryl hydrocarbon receptors 17.269631675874
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.160220994475 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.160220994475
10007457 URB602 565460-15-3 >98% 2005-09-06 42.426367403314 urb602 monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic 42.426367403314
10812 Vaspin (human) Monoclonal Antibody (Clone VP63) - 2011-06-27 11.504834254143 vaspin-human-monoclonal-antibody-clone-vp63 OL-64; Visceral Adipose Tissue-Derived Serine Protease Inhibitor; Serpin A12 antibodies antiserum serum western blot WB immunoblotting ELISA enzyme-linked immunosorbent assay serpin adipocytokine immune response inflammation obesity insulin 11.504834254143
10010519 Vialinin A 858134-23-3 ≥98% 2008-07-25 32.692872928176 vialinin-a Terrestrin A .beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant 32.692872928176
10009023 (+)WIN 55212-2 (mesylate) 131543-23-2 >98% 2006-10-05 42.978506122490 -win-55212-2-mesylate WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic 42.978506122490
13246 YM-58483 223499-30-7 ≥98% 2009-11-16 2.185497237569 ym-58483 BTP 2 calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT 2.185497237569
13665 YS121 Exclusive 916482-17-2 ≥98% ✓ 2010-04-02 20.386180939226 ys121 Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition Pyrimidines inhibits PGs YS 121 YS-121 20.386180939226
13271 ZLJ-6 Exclusive 1051931-39-5 ≥98% ✓ 2009-06-17 38.592334254143 zlj-6 inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 38.592334254143
10008652 (±)-α-CMBHC 7083-09-2 ≥98% 2006-10-18 5.024498816100 -cmbhc vitamin E tocopherals tocotrienols a-CEHC alpha-CEHC .alpha.-CEHC a-tocopherol alpha-tocopherol .alpha.-tocopherol metabolites g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienols HepG2 cells a-CMBHC alpha-CMBHC .alpha.-CMBHC a-CMHHC alpha-CMHHC .alpha.-CMHHC rac rifmpicin CYP3A cytochromes P450s w-oxidation omega-oxidation .omega.-oxidation b-oxidation beta-oxidation .beta.-oxidation 5.024498816100
10008377 α-Tocotrienol 58864-81-6 >98% 2006-10-18 20.203701657458 -tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 toxicity HT4 cytosolic glutamatec-Src kinases 12-lipoxygenases 12-LOs 20.203701657458
10008494 γ-Tocotrienol 14101-61-2 >98% 2006-10-20 16.218591160221 -tocotrienol g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans hypertensive hypertension systolic blood pressures NOS nitric oxides synthases vessels malignant sympathoadrenal +SA mouse murine rats mammary epithelial cells 16.218591160221
10008513 δ-Tocotrienol 25612-59-3 >98% 2006-10-20 11.384290976058 -tocotrienol d-Tocotrienol delta-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neurons neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 cytotoxicity inhibits inhibitors inhibition HAECs U937 monocytic cells VCAM-1 11.384290976058
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?